<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-130747" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Malignant Pleural Effusion</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sanjeev</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boster</surname>
            <given-names>Joshua</given-names>
          </name>
          <aff>Uniformed Services University of the Health Sciences</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjeev Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joshua Boster declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-130747.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Malignant pleural effusion (MPE) has an incidence of 500,000 new cases a year in the United States and Europe and has long been recognized as a cause of significant morbidity in patients with advanced cancer. Associated loculations have been identified as a poor prognostic factor.</p>
        <p>Diagnosing&#x000a0;MPE typically involves a combination of clinical assessment, imaging studies, and laboratory analysis of pleural fluid. Symptoms such as dyspnea, chest pain, and cough prompt further evaluation, often starting with a chest x-ray or computed tomography to detect fluid accumulation. Thoracentesis allows for cytological examination to identify malignant cells. Additional tests like pleural biopsy or biomarkers may be conducted to confirm the diagnosis. Advanced imaging techniques and molecular testing can aid in determining the primary malignancy and guiding treatment strategies.</p>
        <p>Management of malignant pleural effusion involves therapeutic thoracentesis for symptom relief, pleurodesis or indwelling pleural catheters to prevent fluid recurrence, and treatment of the underlying malignancy to address the root cause. Spengler was the first to perform chemical pleurodesis using hypertonic glucose in 1901. Controversy over the ideal agent for this procedure has evolved since then. However, talc has been recognized as the most widely used and studied agent.</p>
        <p>This activity for healthcare professionals is designed to enhance learners' competence in evaluating and managing MPE. Participants gain a deeper understanding of the condition's pathogenesis, various clinical presentations, and evidence-based diagnostic and management strategies. Greater proficiency prepares learners to work within an interprofessional team caring for patients with MPE.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate malignant pleural effusion from other causes of pleural effusion using cytological examination and molecular testing.</p></list-item><list-item><p>Screen for poor prognostic factors, such as loculations, to better stratify patients for appropriate interventions in those with malignant pleural effusion.</p></list-item><list-item><p>Apply evidence-based guidelines for therapeutic thoracentesis, pleurodesis, and indwelling pleural catheters to manage symptoms and prevent fluid recurrence in individuals with malignant pleural effusion.</p></list-item><list-item><p>Collaborate and communicate effectively with the interprofessional team to educate, treat, and monitor patients with malignant pleural effusion to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=130747&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=130747">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-130747.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Malignant pleural effusion (MPE) is characterized by malignant cells in the pleural fluid.<xref ref-type="bibr" rid="article-130747.r1">[1]</xref> The presence of MPE denotes systemic dissemination of cancer and&#x000a0;meets the criteria for&#x000a0;M1a disease, as per the American Joint Committee on Cancer TNM (with T describing the size of the tumor and any spread of cancer into nearby tissue; N describing&#x000a0;the spread of cancer to nearby lymph nodes; and M describing the metastasis staging system).<xref ref-type="bibr" rid="article-130747.r2">[2]</xref> Malignant cells from pleural lavage performed in patients without a coexistent pleural effusion have been identified as an indicator of micrometastatic disease and are associated with a higher recurrence rate and poorer survival.<xref ref-type="bibr" rid="article-130747.r3">[3]</xref> The tumor or blood-borne spread may directly affect the parietal and visceral pleurae.<xref ref-type="bibr" rid="article-130747.r4">[4]</xref> While secondary spread from the visceral pleura may involve the parietal pleura, direct seeding of the latter has also been described.<xref ref-type="bibr" rid="article-130747.r5">[5]</xref>&#x000a0;</p>
        <p>The pathophysiology is attributed to a disturbance of the Starling forces that govern and dictate fluid biomechanics within the pleural space.<xref ref-type="bibr" rid="article-130747.r6">[6]</xref> Pleural fluid production is influenced by the difference&#x000a0;between hydrostatic and oncotic pressures within the pulmonary circulation and pleural space. Meanwhile, absorption is predominantly controlled by lymphatic vessels in the parietal pleura, which actively transport excess fluid into the lymphatic system for drainage into the bloodstream.<xref ref-type="bibr" rid="article-130747.r7">[7]</xref> Excess fluid may accumulate as a result of an inability to drain the fluid from the pleural space, which has been postulated to arise as a result of the clogging of the stomata within the parietal pleura or metastatic involvement of hilar and mediastinal lymph nodes.<xref ref-type="bibr" rid="article-130747.r8">[8]</xref></p>
        <p>Lung, breast, and hematological malignancies are the major&#x000a0;cancers associated with direct, contiguous, or hematogenous pleural involvement.&#x000a0;About 50% to 55% of patients with pleural involvement develop effusion.<xref ref-type="bibr" rid="article-130747.r9">[9]</xref> Wet pleural involvement is associated with a poorer prognosis than dry pleural disease.<xref ref-type="bibr" rid="article-130747.r10">[10]</xref> Between 42% and 77% of effusions in cancer patients have been documented to be exudative. The incidence of eosinophilic pleural effusions, defined as exudative pleural effusions containing more than 10% eosinophils, has gradually increased in recent years, reflecting efforts to distinguish malignant eosinophilic pleural effusion as a distinct entity.<xref ref-type="bibr" rid="article-130747.r11">[11]</xref><xref ref-type="bibr" rid="article-130747.r12">[12]</xref> While malignant pleural involvement may be a cause of effusion in a patient with cancer, other etiologies also need to be considered among the differential.<xref ref-type="bibr" rid="article-130747.r13">[13]</xref></p>
        <p>MPEs must be differentiated from paramalignant pleural effusions, which are not caused by direct pleural involvement by the tumor.<xref ref-type="bibr" rid="article-130747.r14">[14]</xref> A trapped lung is an entity characterized by the failure of a chronically nonexpanded lung to reexpand following drainage of the pleural fluid, which may be caused by extensive involvement of the visceral pleura.<xref ref-type="bibr" rid="article-130747.r15">[15]</xref> Septated pleural effusions, characterized by the development of septated fibrin pockets, may represent an underlying cause of failure to achieve successful drainage and complete resolution of dyspnea.<xref ref-type="bibr" rid="article-130747.r16">[16]</xref>&#x000a0;</p>
        <p>The global incidence of MPE is 70 cases per 100,000 people. In the United States, MPE led to 361,270 hospital admissions in 2016, incurring costs of $10.1 billion. Consequently, MPE substantially impacts the healthcare system due to its high rate of hospital readmissions and significant resource utilization.<xref ref-type="bibr" rid="article-130747.r17">[17]</xref> MPE significantly impacts patients' quality of life, causing symptoms such as breathlessness, pain, cachexia, fatigue, and reduced daily activity. The condition is also associated with a poor prognosis, with a median survival rate of 3 to 12 months.<xref ref-type="bibr" rid="article-130747.r18">[18]</xref></p>
        <p>Dyspnea is the most common presenting complaint associated with pleural involvement by the tumor.<xref ref-type="bibr" rid="article-130747.r19">[19]</xref> Management goals include palliation of symptoms, with minimal impact on the quality of life, while ensuring treatment cost-effectiveness.<xref ref-type="bibr" rid="article-130747.r20">[20]</xref>&#x000a0; Therapeutic approaches vary widely, given the broad range of treatment options. However, a concerted effort has been made recently to move toward patient-related outcomes compared to successful pleurodesis as markers of successful palliation.<xref ref-type="bibr" rid="article-130747.r21">[21]</xref> The role of vascular endothelial growth factor and host-tumor cell interactions in the pleural microenvironment (consisting of inflammatory, mesothelial, and endothelial cells) has been the subject of growing scrutiny.<xref ref-type="bibr" rid="article-130747.r22">[22]</xref><xref ref-type="bibr" rid="article-130747.r23">[23]</xref><xref ref-type="bibr" rid="article-130747.r24">[24]</xref> Novel immunotherapy approaches have been targeted toward understanding the role of the CD8+ T-cells and the associated immune responses to translocated microbial agents in the pathogenesis of this condition.</p>
      </sec>
      <sec id="article-130747.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The development of MPE is multifactorial. Identifying these influences can guide treatment decisions.</p>
        <p>
<bold>Anatomical Factors</bold>
</p>
        <p>Normal pleural space lies between the parietal and visceral pleurae. While the parietal pleura lines the inner thoracic wall, including the bilateral medial mediastinum, subcostal right and left diaphragmatic leaflets, inner ribs, and associated musculature, the visceral pleura lies in close approximation with the lung parenchyma. The visceral and parietal pleurae join at the hilum.<xref ref-type="bibr" rid="article-130747.r25">[25]</xref> Close apposition and maintenance of negative pressure within the intrapleural space ensure adherence of visceral to parietal pleura. Pleural fluid under normal physiological conditions also promotes the sliding motion of the parietal over the visceral pleura.<xref ref-type="bibr" rid="article-130747.r26">[26]</xref>&#x000a0;</p>
        <p>The average fluid volume in the pleural space measures 10 mL/0.13 (0.26 +/- 0.1) mL/kg body weight.<xref ref-type="bibr" rid="article-130747.r27">[27]</xref>&#x000a0;Intrinsic factors like direct tumor cell infiltration, hormonal disequilibrium, anatomical disruption, and extrinsic factors that include limited respiratory motion, pleural stomata blockage, and mechanical compression interfere with the ability of the pleural lymphatics to function effectively. Both intrinsic and extrinsic factors contribute to a decreased pleural fluid resorption, with the resultant accumulation of excess fluid in the pleural space.<xref ref-type="bibr" rid="article-130747.r25">[25]</xref></p>
        <p>
<bold>Physiological Factors</bold>
</p>
        <p>Increased pleural fluid production and decreased reabsorption have been associated with the development of MPE. Tumor cells' capacity to initiate this cycle likely hinges on a unique transcriptional repertoire, leading to significant vasoactive events within the pleural space.<xref ref-type="bibr" rid="article-130747.r28">[28]</xref></p>
        <p>
<bold>Molecular Factors</bold>
</p>
        <p>Molecules predisposing to the development of pleural vessels' hyperpermeability, which leads to the overproduction of pleural fluid, comprise 3 different chemical mediators.<xref ref-type="bibr" rid="article-130747.r29">[29]</xref> The first class consists of inflammatory cytokines such as interleukin 2, tumor necrosis factor, and interferon.<xref ref-type="bibr" rid="article-130747.r30">[30]</xref> The second group comprises proangiogenic molecules such as angiopoietin 1 and 2. The third includes molecules such as vascular endothelial growth factor, chemokine (C-C motif ligand), matrix metalloproteinases, and osteopontin, which have been implicated directly in the pathogenesis of increased vascular permeability.<xref ref-type="bibr" rid="article-130747.r31">[31]</xref><xref ref-type="bibr" rid="article-130747.r32">[32]</xref></p>
        <p>
<bold>Genetic Factors</bold>
</p>
        <p>Mutations in <italic toggle="yes">KRAS, EGFR, MET, BRAF, PIK3CA,</italic> and <italic toggle="yes">RET</italic> are associated with the development of MPE. Coupled with advancements in MPE sequencing techniques, identifying these genes may pave the way for targeted therapies in the near future.<xref ref-type="bibr" rid="article-130747.r33">[33]</xref><xref ref-type="bibr" rid="article-130747.r34">[34]</xref></p>
        <p>
<bold>Impact on Respiratory Physiology</bold>
</p>
        <p>The development of pleural effusion has been associated with a reduction in the partial pressure of oxygen in the blood. The occurrence of a mild intrapulmonary shunt also predisposes to the development of reduced arterial oxygenation. A dramatic relief in the sensation of breathlessness following a successful thoracentesis procedure has also led to an added emphasis on the impact of pleural fluid accumulation on respiratory dynamics.</p>
        <p>The activation of mechanoreceptors in response to pleural fluid accumulation, stretch, cough, and altered lung volumes has been shown to underlie the pathophysiology of dyspnea in MPE. Hemidiaphragmatic movement alterations and the diaphragm's paradoxical movement have been identified. Shifts in inspiratory muscle pressure-volume curves, predisposing to an unfavorable pressure-volume interdependence between increased thoracic volume and pressure, have resulted in pleural fluid accumulation. Length-tension relationship alterations have also been shown to predispose to dyspnea.<xref ref-type="bibr" rid="article-130747.r35">[35]</xref><xref ref-type="bibr" rid="article-130747.r36">[36]</xref></p>
      </sec>
      <sec id="article-130747.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>MPE is characterized by fluid buildup between the lung and the chest wall due to cancer cells in the pleura. The condition is a frequent complication of cancer, with approximately 500,000 new cases reported annually in the United States and Europe combined. MPE affects up to 20% of patients with cancer and can be linked to any type of cancer, including primary pleural malignancies like mesothelioma and secondary metastases from cancers such as lung, breast, and ovarian neoplasms.</p>
        <p>Effusions usually signify advanced malignancy, with an overall survival approaching 3 to 12 months after initial diagnosis.<xref ref-type="bibr" rid="article-130747.r37">[37]</xref> The 5-year survival of lung cancer patients with wet pleural disease is estimated to be 3%.<xref ref-type="bibr" rid="article-130747.r38">[38]</xref> While small cell carcinoma cells directly invade the pleura, non-small cell lung cancer causes indirect impairment of pleural lymphatic function.<xref ref-type="bibr" rid="article-130747.r39">[39]</xref><xref ref-type="bibr" rid="article-130747.r40">[40]</xref>&#x000a0;</p>
        <p>Ipsilateral pleural involvement is seen in 90% of lung cancer cases.<xref ref-type="bibr" rid="article-130747.r41">[41]</xref> Contralateral pleural effusion is seen in 10% of cases.<xref ref-type="bibr" rid="article-130747.r42">[42]</xref> Between 2% and 11% of patients with breast cancer present with MPE, which is usually caused by direct dissemination via pleural lymphatics. Most cases of breast cancer-related MPE are associated with triple-negative disease that has a poor prognosis.<xref ref-type="bibr" rid="article-130747.r43">[43]</xref> An elevated Ki-67 in the pleural fluid is also associated with a poor outcome.<xref ref-type="bibr" rid="article-130747.r44">[44]</xref><xref ref-type="bibr" rid="article-130747.r45">[45]</xref></p>
        <p>Pleural effusion in ovarian cancer may represent a comparatively better prognosis when compared to other tumors. About 15% of patients may present with wet pleural disease as the first sign of cancer.<xref ref-type="bibr" rid="article-130747.r46">[46]</xref> Positive pleural fluid cytology represents the International Federation of Gynecology and Obstetrics (FIGO) stage IV-a disease.<xref ref-type="bibr" rid="article-130747.r47">[47]</xref> While over three-fourths of patients present with ipsilateral disease, one-fourth of cases may show bilateral involvement. MPE is seen in both Hodgkin and non-Hodgkin disease.<xref ref-type="bibr" rid="article-130747.r48">[48]</xref><xref ref-type="bibr" rid="article-130747.r49">[49]</xref><xref ref-type="bibr" rid="article-130747.r50">[50]</xref>&#x000a0;</p>
        <p>While 20% of patients with Hodgkin lymphoma may present with MPE at the time of diagnosis, effusions may represent a disease progression in around 60% of patients. MPE is associated with a poor prognosis and may represent chemotherapy-resistant disease.<xref ref-type="bibr" rid="article-130747.r51">[51]</xref> Diffuse large B-cell and follicular lymphoma represent the leading causes of non-Hodgkin lymphoma presenting with MPE.</p>
        <p>Both pleural space infiltration and tumor-immune cell interactions in the pleural microenvironment represent underlying pathophysiological mechanisms.<xref ref-type="bibr" rid="article-130747.r50">[50]</xref><xref ref-type="bibr" rid="article-130747.r52">[52]</xref> MPE associated with unusually aggressive malignant mesothelioma is seen in nearly 50% to 94% of cases and represents a distinct biologically active disease process that protects the tumor from chemotherapy and promotes tumor growth.<xref ref-type="bibr" rid="article-130747.r53">[53]</xref> Bilateral pleural effusions are seen in 15% of those who are noncritically ill and 55% of the critically ill population.<xref ref-type="bibr" rid="article-130747.r54">[54]</xref><xref ref-type="bibr" rid="article-130747.r55">[55]</xref></p>
      </sec>
      <sec id="article-130747.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pleura can be invaded by lymphangitic spread or direct infiltration from neighboring structures such as the diaphragm, pericardium, and chest wall. However, autopsy studies indicate that tumor cells primarily reach the pleura via the bloodstream, initially affecting the visceral pleura. From there, malignant cells spread to the parietal pleura through either tumor seeding along adhesions or exfoliation and floating in the pleural fluid. Tumor cells adhere to the mesothelium, evade the pleural immune defenses, invade the pleural tissue, and access necessary nutrients and growth factors upon reaching the parietal pleura.</p>
      </sec>
      <sec id="article-130747.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A brief clinical history helps identify the various MPE etiologies. Identifying various comorbidities helps determine the patient's physiological reserve and may have management implications.</p>
        <p>
<bold>Historical Features</bold>
</p>
        <p>Clinical presentation depends upon the extent of effusion, rapidity of development, and physiological reserves of the patient.<xref ref-type="bibr" rid="article-130747.r56">[56]</xref> Common MPE symptoms include dyspnea, pain, cough, and clubbing.</p>
        <p>
<bold>Dyspnea</bold>
</p>
        <p>Dyspnea is the most common presenting complaint&#x000a0;arising from pleural effusion, seen in more than 50% of all cases.<xref ref-type="bibr" rid="article-130747.r57">[57]</xref> Mechanical factors such as a decrease in chest wall compliance, altered biomechanics resulting from a contralateral mediastinal shift, decrease in ipsilateral lung volume, activation of compensatory reflex phenomenon (from chest wall receptors), and caudal displacement of the diaphragm have been identified as contributory factors. A sense of breathlessness out of proportion to the amount of collected fluid may be seen due to coexistent lung collapse, pulmonary arterial hypertension, and ventilation-perfusion mismatch.<xref ref-type="bibr" rid="article-130747.r58">[58]</xref></p>
        <p>Dyspnea in cancer may cause functional impairment and can be assessed using the unidimensional and multidimensional scale.<xref ref-type="bibr" rid="article-130747.r59">[59]</xref> While a numerical rating and visual analog scales have been commonly used to measure dyspnea, the oxygen cost diagram, Borg scale, modified Borg scale, and St George respiratory symptom assessment questionnaire have also been used.<xref ref-type="bibr" rid="article-130747.r60">[60]</xref><xref ref-type="bibr" rid="article-130747.r61">[61]</xref><xref ref-type="bibr" rid="article-130747.r62">[62]</xref><xref ref-type="bibr" rid="article-130747.r63">[63]</xref>&#x000a0;</p>
        <p>Other assessment tools include the dyspnea interview schedule, pulmonary functional status scale, and baseline dyspnea index.<xref ref-type="bibr" rid="article-130747.r64">[64]</xref> Nonpharmacological approaches in managing dyspnea in advanced disease focus on the subjective experience of breathlessness. Emphasizing the need to quantify the impact of dyspnea on functional activities of daily living necessitates using multidimensional scales to assess breathlessness. A minimal clinically significant difference (MCID) of approximately 10 on a visual analog scale of 100 signals a clinically important improvement in chronic breathlessness in clinical trials.<xref ref-type="bibr" rid="article-130747.r65">[65]</xref></p>
        <p>
<bold>Pain</bold>
</p>
        <p>Chest wall pain signifies the presence of underlying chest wall involvement or malignant pleural mesothelioma.<xref ref-type="bibr" rid="article-130747.r66">[66]</xref> Visceral pain from pleural involvement may increase upon taking a deep breath, a manifestation known as pleuritic chest pain.<xref ref-type="bibr" rid="article-130747.r67">[67]</xref> However, a dull, aching pain may be more common than the classically described pleuritic pain. Pain radiation to the right shoulder may signal diaphragmatic involvement. Chest pain may also signal localized chest wall involvement or rib fractures.</p>
        <p>
<bold>Cough</bold>
</p>
        <p>Coughing may be productive and associated with hemoptysis. This symptom denotes underlying pleural inflammation, which may accompany tumor involvement of the pleura or bronchi. Constitutional symptoms such as loss of appetite, loss of weight, easy fatiguability, and lethargy may indicate advanced disease.<xref ref-type="bibr" rid="article-130747.r68">[68]</xref></p>
        <p>
<bold>Clubbing</bold>
</p>
        <p>Lovibond and Schamroth signs, along with a distal phalangeal to interphalangeal depth ratio greater than 1, are physical indicators that aid in determining the presence of clubbing.<xref ref-type="bibr" rid="article-130747.r69">[69]</xref><xref ref-type="bibr" rid="article-130747.r70">[70]</xref> Depth at the nail bed is compared with depth at the interphalangeal fold. Values greater than 1 indicate a diagnosis of finger clubbing, irrespective of the patient's age. Measurements are made using a Harpenden skinfold caliper.<xref ref-type="bibr" rid="article-130747.r71">[71]</xref> Tissue hypoxia, chronic inflammation, and abnormal vascularization have been shown to underlie the pathogenesis of clubbing.<xref ref-type="bibr" rid="article-130747.r72">[72]</xref></p>
        <p>
<bold>Symptomatology related to paraneoplastic manifestations</bold>
</p>
        <p>Paraneoplastic manifestations include muscle weakness, as happens in Lambert-Eaton myasthenic syndrome from small-cell lung cancer.<xref ref-type="bibr" rid="article-130747.r73">[73]</xref> Drowsiness, obtundation, and seizures may occur from hyponatremia associated with the syndrome of inappropriate antidiuretic hormone.<xref ref-type="bibr" rid="article-130747.r74">[74]</xref> Squamous cell lung cancer can cause hypercalcemia, resulting in confusion and increased frequency of micturition.<xref ref-type="bibr" rid="article-130747.r75">[75]</xref> Cushing striae, obesity, buffalo hump, and proximal muscle weakness may all manifest from Cushing syndrome due to ectopic adrenocorticotropic hormone production from small cell lung cancer.<xref ref-type="bibr" rid="article-130747.r76">[76]</xref>&#x000a0;</p>
        <p>Headache, engorged anterior chest wall veins, dyspnea, voice alteration, confusion, obtundation, and facial and brachial swelling can arise from superior vena cava obstruction by small cell lung cancer.<xref ref-type="bibr" rid="article-130747.r77">[77]</xref> Miosis, ptosis, anhidrosis, and apparent enophthalmos comprise Horner syndrome from a superior sulcus or Pancoast tumor due to adenocarcinoma.<xref ref-type="bibr" rid="article-130747.r78">[78]</xref> Hypertrophic pulmonary osteoarthropathy is most commonly associated with non-small cell lung cancer.<xref ref-type="bibr" rid="article-130747.r79">[79]</xref><xref ref-type="bibr" rid="article-130747.r80">[80]</xref></p>
        <p>
<bold>Other parts of history</bold>
</p>
        <p>A history of occupational asbestos exposure should be sought due to asbestos&#x02019; frequent association with lung cancer and mesothelioma.<xref ref-type="bibr" rid="article-130747.r81">[81]</xref> A family history of malignancy may offer a clue to an underlying malignancy. A review of medications should also be performed, as drugs such as amiodarone, nitrofurantoin, and methotrexate are associated with developing exudative effusion.<xref ref-type="bibr" rid="article-130747.r82">[82]</xref></p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>The physical examination complements the patient's history by providing objective findings that may account for the symptoms of pleural effusion. A thorough and accurate physical examination can guide subsequent diagnostic and management approaches. All parts of the examination are important, but special attention must be given to the general physical examination and chest inspection, percussion, and auscultation.</p>
        <p>
<bold>General physical examination</bold>
</p>
        <p>Poor performance status may signal an urgent need for imminent palliation. Prognostication may be performed using a palliative prognostic scale, a component of the palliative prognostic index (PPI). A score greater than 4.5 on the PPI may signal a survival of less than 6 weeks.<xref ref-type="bibr" rid="article-130747.r83">[83]</xref> Pallor, clubbing (hypertrophic pulmonary osteoarthropathy), and left supraclavicular lymphadenopathy (Trosier sign) may signal advanced illness.</p>
        <p>
<bold>Inspection</bold>
</p>
        <p>Chest inspection visually identifies signs of pleural effusion. This step may reveal asymmetrical chest wall expansion, tracheal shift, intercostal fullness, Trail sign, scars of previously performed thoracocentesis or biopsies, and a predominance of abdominal breathing.<xref ref-type="bibr" rid="article-130747.r84">[84]</xref></p>
        <p>
<bold>Percussion and cardinal rules</bold>
</p>
        <p>Dullness is usually observed on percussion. The percussion note has been traditionally described as woody and dull. Joseph Leopold Auenbrugger is regarded as the inventor of direct percussion, which has been replaced mainly by the digit-to-digital percussion method. Percussion is preferentially performed with the patient sitting up. Topographic comparative percussion is performed in the apical regions, fourth and fifth intercostal spaces (right middle and lingular lobes), and basal lung areas.</p>
        <p>During percussion, the middle finger of the left hand (pleximeter) should be firmly placed on the chest wall, with the other fingers off. The middle finger of the right hand (plessor) strikes the middle phalanx of the pleximeter finger perpendicularly in the intercostal spaces or directly over the clavicle, moving from more resonant to less resonant areas or vice versa, ensuring differences between areas are felt. The plessor finger's sudden movement originates from the relaxed wrist, keeping the pleximeter finger parallel to the percussed organ's border. Notes are compared bilaterally.</p>
        <p>The force of the stroke of the plessor finger depends upon patient factors (eg, age, sex, and build), tissue type, differential diagnoses being considered, the area being examined, and thickness of the chest wall. Damping of the percussion stroke can be avoided by withdrawing the plessor finger immediately after striking the middle phalanx. Both the sound and the feeling of the percussion note are considered crucial to formulating a differential diagnosis. Heavy percussion enhances resonance in large lung areas, potentially masking subtle abnormalities in sound quality, necessitating a gentler technique to avoid missing small note impairments.<xref ref-type="bibr" rid="article-130747.r85">[85]</xref><xref ref-type="bibr" rid="article-130747.r86">[86]</xref></p>
        <p>
<bold>Auscultation</bold>
</p>
        <p>Diminished or absent breath sounds are present on auscultation. A pleural rub is usually heard in dry pleurisy.</p>
        <p>
<bold>Egophony</bold>
</p>
        <p>Egophony refers to a change in the vocal timber from E to A (but not pitch or volume). Egophony is usually heard as a high-pitched nasal sound and described by Laennec as the bleating of a goat. This sound is characterized by its intensity and suddenness&#x02014;usually confined over a small area on one side of the chest. An absence of a similar change in sound over the contralateral side should be used before making a definitive diagnosis. The mechanism underlying egophony is fluid accumulation enhancing the transmission of high-frequency sounds while filtering out low-frequency sounds.&#x000a0;&#x000a0;</p>
        <p>
<bold>Whispering pectoriloquy</bold>
</p>
        <p>Pectoriloquy is the increased voice resonance while passing through the lung structures. A whispered sound is heard clearly after placing a stethoscope over the patient's chest. Both whispered pectoriloquy and egophony may be appreciated at the upper border of the pleural effusion.&#x000a0;</p>
        <p>
<bold>Summary of physical findings</bold>
</p>
        <p>Findings of dullness to percussion and decreased vocal fremitus have been used clinically to diagnose pleural effusion. Percussive dullness makes the diagnosis likely, though a chest radiograph is best obtained for confirmation. If clinical suspicion is low, the absence of reduced vocal fremitus reduces the likelihood of diagnosis, typically suggesting against a chest radiograph unless reduced vocal fremitus is detected on physical examination.</p>
        <p>According to Auenbrugger and Forbes, dullness is a prerequisite for diagnosing pleural effusion. However, this particular physical finding may be challenging to discern in bilateral pleural effusion. Percussive sounds have been shown to penetrate up to a maximum depth of 6 cm (2 cm of chest wall and 4 cm of fluid). At least 500 mL of fluid should be present in the pleural cavity to yield positive findings on physical examination. Significant tachypnea, markedly decreased chest expansion, absent tactile fremitus and breath sounds, contralateral tracheal or mediastinal shift (Trail sign and tracheal deviation), bulging intercostal spaces, and egophony have been shown to correlate with accumulation of more than 1500 mL of fluid in the pleural space.<xref ref-type="bibr" rid="article-130747.r87">[87]</xref></p>
      </sec>
      <sec id="article-130747.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of suspected MPE cases is often accomplished using various modalities. Specific techniques involve imaging and histopathological diagnosis, as discussed below.</p>
        <p>
<bold>Imaging</bold>
</p>
        <p>Imaging is crucial in diagnosing MPE as it helps detect and evaluate pleural fluid accumulation, assess the extent of pleural involvement, identify underlying malignancies, guide thoracentesis, and monitor treatment response. Detailed visualization of pleural fluid and underlying structures facilitates precise placement of thoracentesis or chest tubes, helps in planning and monitoring pleurodesis, and&#x000a0;enables the assessment of tumor response to chemotherapy or radiotherapy.</p>
        <p>
<bold>Chest radiograph</bold>
</p>
        <p>A posteroanterior chest radiograph is usually the first-line investigation used for evaluating the signs and symptoms of pleural effusion in the cancer setting.<xref ref-type="bibr" rid="article-130747.r88">[88]</xref> A minimum quantity of 200 mL of fluid must be present in the pleural space for the diagnosis to be made on a posteroanterior chest radiograph. In comparison, 50 mL of fluid may be visible on a lateral chest radiograph.<xref ref-type="bibr" rid="article-130747.r89">[89]</xref> Costophrenic angle blunting on the posteroanterior view requires the presence of 175 mL of fluid.<xref ref-type="bibr" rid="article-130747.r90">[90]</xref> The fluid volume of fewer than 500 mL (detected in roughly 10%-15% effusion) does not usually produce symptoms.</p>
        <p>Costophrenic angle blunting, mediastinal shift, rib crowding, and hemidiaphragm elevation are radiographic findings that may point toward a diagnosis. A massive effusion occupies an entire hemithorax and is more commonly associated with a mediastinal shift and diaphragmatic inversion. The presence of a massive effusion, loculation, and loss of volume of the lung ipsilateral to the involved site should increase suspicion of&#x000a0;an underlying malignant etiology.<xref ref-type="bibr" rid="article-130747.r91">[91]</xref> A mass lesion may also be visualized in the case of a lung primary. Hilar prominence may suggest a central lesion or lymphadenopathy. The absence of a mediastinal shift may represent underlying fibrosis (fixity of the mediastinum) or extensive pleural involvement (malignant pleural mesothelioma).<xref ref-type="bibr" rid="article-130747.r92">[92]</xref></p>
        <p>
<bold>Thoracic ultrasound</bold>
</p>
        <p>Thoracic ultrasonography is more sensitive than chest radiography.<xref ref-type="bibr" rid="article-130747.r93">[93]</xref> Ultrasonography may help diagnose smaller amounts of fluids and guide diagnostic and therapeutic procedures.<xref ref-type="bibr" rid="article-130747.r94">[94]</xref> Transducer probes of 3.5 to 5 MHz frequency can provide a good penetration depth and optimum spatial resolution. Septations (loculated collections), hemothorax, and organized collections may be identified.<xref ref-type="bibr" rid="article-130747.r95">[95]</xref> An ultrasound may also distinguish between an effusion, consolidation, and thickened pleura. Pleural metastases may be characterized as relatively small lenticular hypoechoic masses in close apposition to the chest wall or masses with complex echogenicity.<xref ref-type="bibr" rid="article-130747.r96">[96]</xref>&#x000a0;</p>
        <p>The shred sign can diagnose pulmonary nontranslobar consolidation with a sensitivity of 90% and a specificity of 98%.<xref ref-type="bibr" rid="article-130747.r97">[97]</xref> Lung movement may be visualized as pleural sliding, which may be lost with the development of postprocedure pneumothorax.<xref ref-type="bibr" rid="article-130747.r98">[98]</xref> Pleural thickening (&#x0003e;1 cm), pleural nodularity, visceral pleural thickening, and diaphragmatic thickening (&#x0003e;7 mm) may also indicate malignancy.&#x000a0;</p>
        <p>Evidence supports the use of preprocedural ultrasonography in identifying the optimal thoracentesis site. A grading system proposed by Smargiassi et al uses anatomical extent, visible radiological landmarks, and several intercostal spaces to stratify the&#x000a0;severity of pleural effusion. A large pleural effusion is classified as one where the upper lung lobe is partially displaced, includes atelectasis of the lower lobe or partial atelectasis of the upper lobe, and involves 3 to 4 intercostal spaces. A massive pleural effusion is characterized by the total collapse of the lung, atelectasis of the whole lung with the hilum visible, and involvement of 4 or more intercostal spaces.<xref ref-type="bibr" rid="article-130747.r99">[99]</xref> Thoracic ultrasound has also been associated with reducing the incidence of hemothorax and pneumothorax following thoracentesis.<xref ref-type="bibr" rid="article-130747.r100">[100]</xref> Ultrasound imaging also has a role in the rapid identification of postprocedural pneumothorax.</p>
        <p>
<bold>Contrast-enhanced chest computed tomography</bold>
</p>
        <p>Mediastinal lymph node involvement and associated parenchymal disease may be better visualized on computed tomography (CT), considered the gold standard screening examination in those with underlying pleural malignancy.<xref ref-type="bibr" rid="article-130747.r101">[101]</xref> Circumferential pleural thickening, pleural nodularity, parietal pleural thickening of more than 1 cm, and mediastinal pleural involvement&#x000a0;are all considered pointers of a diagnosis of malignancy. CT scanning has a high specificity and poor sensitivity. Other potential limitations include the inability to distinguish between malignant pleural mesothelioma and pleural metastasis. Nodular pleural thickening, mediastinal pleural thickening, circumferential thickening encasing the lung, and thickening of parietal pleura over 1 cm may also be useful markers in identifying malignant pleural involvement.<xref ref-type="bibr" rid="article-130747.r102">[102]</xref>&#x000a0;</p>
        <p>A CT scan scoring system proposed by Pocel et al for differentiating between malignant and benign conditions includes the following parameters: the presence of pleural lesions measuring more than 1 cm, hepatic metastasis, pulmonary mass or nodule measuring more than 1 cm, pericardial effusion, absence of loculations, and absence of cardiac silhouette enlargement. A score of more than 7 out of 10&#x000a0;may be used to detect malignancy with a sensitivity and specificity of 88% and 94%, respectively.<xref ref-type="bibr" rid="article-130747.r103">[103]</xref>&#x000a0;</p>
        <p>Dual-energy spectral CT imaging, which can generate material decomposition images and monochromatic image sets with fast kilovoltage switching, has been shown to have added utility in distinguishing benign from malignant pleural lesions. A combination of patient age, clinical history, and information on CT value measurement (at both high and low energy levels) and the adequate atomic number obtained in a single spectral scan help identify malignant pleural disease.<xref ref-type="bibr" rid="article-130747.r104">[104]</xref></p>
        <p>
<bold>Positron emission tomography/dynamic imaging</bold>
</p>
        <p>While early or indolent disease may give rise to false negatives, inflammatory pleural involvement, rheumatoid disease, and pleurodesis procedures performed may be associated with false-positive results.<xref ref-type="bibr" rid="article-130747.r105">[105]</xref> Dynamic imaging may help characterize mixed lesions (pleural asbestosis, malignant pleural mesothelioma) and target specific areas within the pleura.<xref ref-type="bibr" rid="article-130747.r106">[106]</xref>&#x000a0;Bury et al first suggested the utility of a scoring system for characterizing pleural disease. This score, which includes unilateral masses or nodules with increased pleural thickening, multiple nodules, effusions with increased F18-fluorodeoxyglucose uptake, and extrapulmonary malignancy, distinguishes benign from malignant disease with 83% sensitivity and 92% specificity.<xref ref-type="bibr" rid="article-130747.r107">[107]</xref></p>
        <p>
<bold>Magnetic resonance imaging</bold>
</p>
        <p>Magnetic resonance imaging (MRI) offers better soft tissue resolution than CT scanning. MRI is more sensitive in detecting chest wall and diaphragmatic involvement.<xref ref-type="bibr" rid="article-130747.r108">[108]</xref><xref ref-type="bibr" rid="article-130747.r109">[109]</xref> The exclusion of MRI-based imaging from diagnostic algorithms can be attributed to higher costs, limited availability, and difficulty in imaging the lung parenchyma. Diffusion-weighted imaging is useful in differentiating between benign and malignant pleural diseases.<xref ref-type="bibr" rid="article-130747.r110">[110]</xref></p>
        <p>
<bold>Histopathological Diagnosis</bold>
</p>
        <p>Histopathological analysis is crucial for MPE, providing detailed information about cell types and tissue architecture that can differentiate malignant cells from reactive mesothelial cells. Techniques such as pleural fluid cytology, cell block preparation, and pleural biopsy, including image-guided and thoracoscopic biopsies, enhance diagnostic accuracy. Despite challenges like low yield and difficulty distinguishing cell types, advancements in histopathological methods and immunohistochemistry significantly improve the detection and characterization of MPE, guiding effective treatment strategies.</p>
        <p>
<bold>Diagnostic thoracentesis</bold>
</p>
        <p>The standard panel of tests that must be performed on a pleural fluid sample includes pleural fluid protein, glucose, pH, lactate dehydrogenase, cytology, and microbiology.<xref ref-type="bibr" rid="article-130747.r111">[111]</xref> About 40 to 60 cc of pleural fluid is considered optimum for diagnosing MPE.<xref ref-type="bibr" rid="article-130747.r112">[112]</xref> While the yield of pleural fluid analysis approaches 6% to 32% for diagnosing mesothelioma, the test has been shown to have a comparatively higher sensitivity in diagnosing adenocarcinoma (80%).<xref ref-type="bibr" rid="article-130747.r113">[113]</xref><xref ref-type="bibr" rid="article-130747.r114">[114]</xref> While primarily exudative, transudative&#x000a0;MPE may be seen in 5% to 10% of cases.<xref ref-type="bibr" rid="article-130747.r115">[115]</xref> Repeat procedures may increase the yield by a third; however, more than 2 repeat procedures are less productive.<xref ref-type="bibr" rid="article-130747.r116">[116]</xref></p>
        <p>
<bold>Pleural fluid analysis</bold>
</p>
        <p>Normal physicochemical characteristics include pH between 7.60 and 7.64, protein levels of less than 2% (2 gm/dL), less than 100 white blood cells per cubic mm, glucose content similar to that of plasma, lactate dehydrogenase (LDH) level less than half of that present within the plasma. The following parameters may&#x000a0;be used in making a diagnosis of malignant etiology underlying the accumulation of pleural fluid: pH less than 7.30, LDH levels greater than 1000 U/l, reduced pleural fluid glucose concentration (30 to 50 mg/dL), and lymphocyte values greater than 50% to 70%.<xref ref-type="bibr" rid="article-130747.r117">[117]</xref></p>
        <p>Pleural fluid tumor marker levels have been used to diagnose MPE. Carcinoembryonic antigen, mucin, and Leu-1 are elevated in effusions with an underlying malignant etiology. In addition to the standard Light criteria, which are based on pleural fluid protein and LDH levels, exudative effusions can be identified by cloudy appearance, specific gravity above 1.020, total proteins of 2.9 g/dL, cholesterol levels, CT scan attenuation, and serum-pleural fluid albumin gradient.<xref ref-type="bibr" rid="article-130747.r118">[118]</xref></p>
        <p>An issue that remains a deterrent in diagnosing malignant effusion using conventional cytology is differentiating malignant cells from reactive mesothelial cells.<xref ref-type="bibr" rid="article-130747.r119">[119]</xref> The inability to study the tissue architecture due to a lack of tissue specimens must also be addressed. Overcrowding of cells and processing artifacts may also contribute to the low yield.<xref ref-type="bibr" rid="article-130747.r120">[120]</xref> The cytocentrifuge or millipore filter can evaluate malignant cells in the pleural fluid.<xref ref-type="bibr" rid="article-130747.r121">[121]</xref></p>
        <p>
<bold>Pleural fluid cell block</bold>
</p>
        <p>The cell-block technique for processing fluids was first introduced in 1896.<xref ref-type="bibr" rid="article-130747.r122">[122]</xref> Retaining tissue fragments, vital to diagnosing, is a potential advantage over conventional cytology.<xref ref-type="bibr" rid="article-130747.r123">[123]</xref> Various cell-block preparation methods include the formalin, agar, and thrombin clot methods.<xref ref-type="bibr" rid="article-130747.r124">[124]</xref> The underlying principle involves the formation of a gel from cross-linking of proteins that do not get dissolved upon the processing of tissue samples.<xref ref-type="bibr" rid="article-130747.r125">[125]</xref> Another advantage of this technique is preserving the antigenicity and cytomorphological characteristics. The increase in sensitivity of the procedure may be attributed to higher cellularity, preservation of cellular architecture, and morphological patterns of malignant cells. Immunohistochemistry analysis and special staining may also be performed on the cell block specimen.<xref ref-type="bibr" rid="article-130747.r126">[126]</xref></p>
        <p>
<bold>Pleural biopsy</bold>
</p>
        <p>Given the limited diagnostic yield of conventional cytology and the absence of standardized protocols for cell block techniques, pleural biopsy is recommended for patients with negative cytology results.<xref ref-type="bibr" rid="article-130747.r127">[127]</xref> Closed pleural biopsy methods like Abrams, Cope, Vim Silverman, or cutting-needle biopsy are commonly used.<xref ref-type="bibr" rid="article-130747.r128">[128]</xref> However, these methods may have reduced yield when used on early-stage tumors or neoplasms with uneven distribution. The procedure's ease and cost-effectiveness make it preferred over more complex techniques such as medical thoracoscopy. An increased yield is noted when this procedure is combined with cytological techniques. A diagnostic yield approaching 60% has been reported using blind closed pleural biopsy. Adding imaging techniques (eg, ultrasonography and CT) may help improve diagnostic yields.<xref ref-type="bibr" rid="article-130747.r129">[129]</xref></p>
        <p>
<bold>Image-guided biopsies</bold>
</p>
        <p>Ultrasound- and CT-guided biopsies have been used to obtain representative pleural samples for diagnostic purposes. Both have shown sensitivity in the range of 70% to 90%. Imaging-guided biopsy can increase the sensitivity of diagnosing MPE to 80%.</p>
        <p>
<bold>Thoracoscopy</bold>
</p>
        <p>Medical thoracoscopy is recommended when effusion thickness is less than 10 mm on a CT scan. This method improves diagnostic accuracy as it allows for direct visualization of the area of interest and tumor tissue sampling. Significant pathological changes in the diseased pleura include nodules, adhesions, plaques, ulcers, and hyperemia. Thoracoscopy has been shown to have a complication rate of less than 8% when performed by trained professionals. Transient chest pain due to the indwelling catheter, cough, and chest discomfort associated with lung reexpansion&#x000a0;after drainage of a large amount of fluid has been reported following medical thoracoscopy.&#x000a0;</p>
        <p>
<bold>Pleural manometry</bold>
</p>
        <p>German physician Heinrich Quincke was the first to pioneer pleural manometry to measure the pressure within the pleural space in 1878. Techniques used to measure pleural pressures include a hemodynamic electronic transducer, electronic manometer, and U-tube water manometer. Hemodynamic electronic transducers provide the most reliable and accurate measures of intrapleural pressures. The thickness of the normal pleural space is 20&#x000a0;&#x003bc;m, and 50 mL of fluid in the pleural space is required to ensure that the effect of local deformation forces on the measurement of pleural pressures can be nullified.</p>
        <p>Elastic forces of the chest wall, lung, and effusion volume influence pressure within the pleural space. Gravity, ventilatory pressures, and forces produced due to cardiac contraction associated with lymphatic drainage generate pleural pressures. Lan et al were the first to describe the utility of manometry in optimizing pleurodesis in those with malignant pleural effusion. Real-time manometry has been proposed to identify an unexpandable lung following thoracentesis. However, consensus is lacking regarding the specific pressure cutoffs that distinguish between normal and unexpanded lungs.</p>
      </sec>
      <sec id="article-130747.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>A definitive procedure is defined as one aimed at providing long-term relief from symptoms associated with pleural effusion.<xref ref-type="bibr" rid="article-130747.r130">[130]</xref> For this reason, serial thoracentesis is not considered a definitive procedure in the joint guidelines published by the European Respiratory Society and the European Association of Cardiothoracic Surgery.</p>
        <p>
<bold>Thoracentesis</bold>
</p>
        <p>The incidence of recurrence after a single thoracentesis procedure was found to be 4.2 days, with a rate of recurrence approaching 98% within 30 days of completing the procedure. Thoracentesis does not aim to prevent fluid reaccumulation or allow continued drainage. The procedure confirms the presence of fluid and lung reexpansion following pleural fluid drainage. No absolute contraindications to thoracentesis have been mentioned. However, small fluid accumulations and ongoing positive pressure ventilation may predispose to the development of pneumothorax. Additionally, both thrombocytopenia and uncorrected coagulopathy predispose to hemorrhage after the procedure.<xref ref-type="bibr" rid="article-130747.r131">[131]</xref></p>
        <p>Tension pneumothorax,&#x000a0;often associated with hemodynamic compromise, may also be seen in the performance of thoracentesis in those receiving positive pressure ventilation.<xref ref-type="bibr" rid="article-130747.r132">[132]</xref> Requisite sedation and analgesia have been recommended in the pediatric population to ensure minimal movements during the procedure.<xref ref-type="bibr" rid="article-130747.r133">[133]</xref> Excessive movements during thoracentesis have been shown to predispose to increased damage to vascular structures and underlying lung parenchyma.<xref ref-type="bibr" rid="article-130747.r134">[134]</xref> The presence of skin infection at the needle insertion site may&#x000a0;promote microbial entry into the pleural space.<xref ref-type="bibr" rid="article-130747.r135">[135]</xref></p>
        <p><bold>Anatomical localization</bold>&#x000a0;</p>
        <p>The normal site for pleural fluid aspiration is the 7th intercostal space in the posterior axillary line (near the scapular tip).<xref ref-type="bibr" rid="article-130747.r136">[136]</xref> Posterior intercostal artery laceration poses a significant bleeding risk during the procedure.<xref ref-type="bibr" rid="article-130747.r137">[137]</xref> The posterior intercostal artery runs within the subcostal groove along the posteroinferior border of the superior rib, which has the neurovascular bundle.<xref ref-type="bibr" rid="article-130747.r138">[138]</xref> A site above the inferior rib should be chosen to avoid the bundle. A decrease in the practical, safe space has been documented in older individuals, along with a considerable variation in the course (mean distance from the spine). Variability has also been demonstrated in the course of the posterior intercostal artery, increasing in more posterior positions.<xref ref-type="bibr" rid="article-130747.r139">[139]</xref></p>
        <p><bold>Conduct of the procedure</bold>&#x000a0;</p>
        <p>While adults may undergo the procedure in the upright, seated, or lateral position, pediatric patients may be held in the burping position by an assistant.<xref ref-type="bibr" rid="article-130747.r140">[140]</xref> The needle insertion site is prepared with chlorhexidine. Draping ensures access to the anatomical area of interest. The skin entry site is localized using the available anatomical landmarks and confirmed with ultrasound. Under all aseptic precautions perpendicular to the skin, the needle is advanced to infiltrate the underlying subcutaneous tissue and reach the periosteum, which may be infiltrated with the local anesthetic agent. The needle must be advanced over the superior border of the inferior rib to avoid injury to the neurovascular bundle, which lies along the lower border of the superior rib within the intercostal space. Gentle aspiration may be carried out until pleural fluid has been obtained.<xref ref-type="bibr" rid="article-130747.r141">[141]</xref>&#x000a0;</p>
        <p>The insertion depth where access to the fluid is obtained should be noted, and an over-the-need catheter should be inserted for atraumatic fluid removal. Attracting a 3-way stopcock along with tubing may facilitate the drainage of large fluid volumes.<xref ref-type="bibr" rid="article-130747.r142">[142]</xref> A heparinized syringe, which needs to be kept closed until the measurement has been completed, may be indicated if a pH measurement has been planned.<xref ref-type="bibr" rid="article-130747.r143">[143]</xref> The procedure may be terminated for pleuritic chest pain, chest tightness, and significant cough, which may signal underlying damage to the lung parenchyma.<xref ref-type="bibr" rid="article-130747.r144">[144]</xref><xref ref-type="bibr" rid="article-130747.r145">[145]</xref>&#x000a0;Large-volume thoracentesis has been defined as removing more than 1 liter of pleural fluid.<xref ref-type="bibr" rid="article-130747.r146">[146]</xref> Thoracentesis tolerance may improve using slower or gravity drainage instead of rapid suction evacuation.</p>
        <p>Repeat thoracentesis is recommended for patients with slow fluid accumulation, potential systemic therapy response, advanced disease, poor performance status, or limited life expectancy. Repeating the procedure is also suitable for patients receiving systemic treatment for underlying malignancies, such as small cell lung cancer, lymphoma, or epidermal growth factor receptor-mutated adenocarcinoma that may prevent fluid reaccumulation.<xref ref-type="bibr" rid="article-130747.r147">[147]</xref>&#x000a0;Delayed pleurodesis, linked to extensive disease and increased pleural tumor burden, can have reduced effectiveness and may cause trapped lung, contraindicating the procedure. In patients with mediastinal shift, monitoring pleural pressure or removing smaller fluid amounts (300-500 mL) at a time may be necessary to prevent complications from a rapid pleural pressure drop.<xref ref-type="bibr" rid="article-130747.r148">[148]</xref><xref ref-type="bibr" rid="article-130747.r149">[149]</xref>&#x000a0;</p>
        <p>Volumes over 1.5 L are associated with reexpansion pulmonary edema. However, some expert groups recommend safely removing 1200 to 1800 mL of pleural fluid in a single session.<xref ref-type="bibr" rid="article-130747.r150">[150]</xref><xref ref-type="bibr" rid="article-130747.r151">[151]</xref> During simultaneous pleural pressure monitoring, negative pressure must not exceed -20 mm Hg. Real-time ultrasonographic guidance is used increasingly to minimize complications like pneumothorax.<xref ref-type="bibr" rid="article-130747.r152">[152]</xref> Bilateral thoracentesis under ultrasonographic guidance has been performed safely in patients with bilateral pleural effusions without causing pneumothorax.</p>
        <p><bold>Complications</bold>&#x000a0;</p>
        <p>While pneumothorax remains a genuine concern, pain, shortness of breath, and vasovagal syncope have also been noted. Cough is known to occur commonly during the procedure. However, only a cough severe enough to cause significant discomfort is an indication for terminating the procedure. Other authors propose procedure termination at the onset of coughing, as this has been shown to denote pulmonary injury. Rare complications include bleeding, reexpansion, pulmonary edema, and organ puncture.<xref ref-type="bibr" rid="article-130747.r153">[153]</xref> Repeat thoracentesis has also been shown to be associated with complications of hypoproteinemia, empyema, pneumothorax, and loculated pleural effusion. History of receiving radiotherapy or superior vena cava obstruction also predisposes patients to develop dilated venous channels,&#x000a0;risking vascular injury.<xref ref-type="bibr" rid="article-130747.r154">[154]</xref></p>
        <p>
<bold>Reexpansion pulmonary edema</bold>
</p>
        <p>Pinault was the first to describe edema occurrence following thoracentesis in 1853. Drainage of more than 1.5 L of fluid has been associated with the development of reexpansion pulmonary edema. This condition has been shown to develop frequently in the first hour following thoracentesis and tends to occur within 24 hours in most patients. Although unilateral edema is a common occurrence, bilateral cases have been described. Pulmonary edema is caused by increased capillary permeability from hypoxia-mediated endothelial injury, free radical damage, surfactant depletion, pulmonary arterial pressure changes, and sudden blood flow and capillary expansion. High perfusion due to pulmonary vasoconstriction, abrupt pressure variations, decreased lymphatic flow, and venous constriction also contribute to its etiopathogenesis.</p>
        <p>Preventing this phenomenon involves avoiding negative intrapleural pressures and prolonged lung collapse.<xref ref-type="bibr" rid="article-130747.r155">[155]</xref> The chronicity of the effusion, bronchial obstruction, and reexpansion technique also impact development.<xref ref-type="bibr" rid="article-130747.r156">[156]</xref> The condition may present asymptomatically (with only radiological signs), with breathlessness, or as acute respiratory distress syndrome.<xref ref-type="bibr" rid="article-130747.r157">[157]</xref> Cough, pink frothy expectoration, and cyanosis may denote severe lung involvement. Infection is considered a close differential. Though the patient may demonstrate initial worsening during the first 1 or 2 days, the pathological process is considered self-resolving and usually resolves within 3 to 5 days of occurrence.<xref ref-type="bibr" rid="article-130747.r158">[158]</xref></p>
        <p>Untreated pulmonary edema may be associated with a poorer outcome and has been estimated to be potentially lethal in 20% of cases.<xref ref-type="bibr" rid="article-130747.r159">[159]</xref> Lung injury predisposes to the development of edema and atelectasis.<xref ref-type="bibr" rid="article-130747.r160">[160]</xref><xref ref-type="bibr" rid="article-130747.r161">[161]</xref> The degree of intrapulmonary shunting, ventilation-perfusion mismatch, decreased compliance, and intraalveolar fluid determine the severity grade.<xref ref-type="bibr" rid="article-130747.r162">[162]</xref> Hypotension may accompany sufficient fluid accumulation within the pulmonary interstitium.<xref ref-type="bibr" rid="article-130747.r163">[163]</xref>&#x000a0;</p>
        <p>Patchy ground-glass opacities, consolidation, interlobar septal thickening, and intralobular interstitial thickening have been described on high-resolution chest CT.<xref ref-type="bibr" rid="article-130747.r164">[164]</xref> Bronchovascular bundle thickening and ill-defined ground-glass opacities have been described less commonly. Supportive management is advised to ensure adequate oxygenation and perfusion till the resolution of lung injury.<xref ref-type="bibr" rid="article-130747.r165">[165]</xref><xref ref-type="bibr" rid="article-130747.r166">[166]</xref> This approach may include serial chest radiographs (showing nonspecific initial findings of unilateral opacification of air spaces), arterial blood gas analysis, supplemental oxygen treatment in the event of hypoxia, and intubation and mechanical ventilation (positive end-expiratory pressure ventilation) in the presence of severe pulmonary involvement.<xref ref-type="bibr" rid="article-130747.r167">[167]</xref></p>
        <p>Hypotension management may require intravenous volume expansion with parenteral fluids, inotropes, and plasma expanders. The use of diuretics is contraindicated due to their tendency to worsen a fluid-depleted state. Adequate positioning with lateral decubitus on the affected side may reduce shunting and improve oxygenation.</p>
        <p>
<bold>Chemical Pleurodesis</bold>
</p>
        <p>Lucius Splengler was the first to perform chemical pleurodesis in 1901. The procedure involves pleural space obliteration and artificial symphysis creation between the visceral and parietal pleura. An inflammatory reaction within the pleural space activates the coagulation cascade, forming fibrogenic cytokines that promote the development of pleurodesis by collagen production.<xref ref-type="bibr" rid="article-130747.r168">[168]</xref> The beneficial effects of pleurodesis were observed within weeks or months of the procedure. The procedure aims to prevent fluid reaccumulation within the pleural space.<xref ref-type="bibr" rid="article-130747.r169">[169]</xref> Pleurodesis is usually offered to patients with advanced cancer not deemed suitable for systemic cancer-directed treatment as a palliative intervention.<xref ref-type="bibr" rid="article-130747.r170">[170]</xref>&#x000a0;</p>
        <p>Active pleurodesis involves mechanically or physically injuring the pleura, such as through mechanical abrasion during video-assisted thoracoscopic surgery or inducing intrapleural adhesions using chemical agents like talc, bleomycin, povidone-iodine, and <italic toggle="yes">Corynebacterium parvum</italic>. Antibiotics (eg, tetracycline, doxycycline, erythromycin, and minocycline), antiseptics (eg, silver nitrate and iodopovidone), chemotherapeutic agents (eg, mitomycin, bleomycin, cytarabine, doxorubicin, and mitoxantrone), microorganisms (<italic toggle="yes">Corynebacterium parvum</italic> and <italic toggle="yes">Streptococcus pyogenes</italic> or OK432), and autologous blood are also used. Both pleural catheters and medical thoracoscopy have been used to introduce sclerosing agents into the pleural cavity. Life expectancy and patient factors are crucial in determining the procedure's acceptability.<xref ref-type="bibr" rid="article-130747.r171">[171]</xref>&#x000a0;Two major contraindications to pleurodesis include the presence of a non-re-expanded or trapped lung and loculated pleural effusion. The type of cancer, extent of pleural involvement, and sclerosant type used for pleurodesis determine the degree of effectiveness of pleurodesis.</p>
        <p>
<bold>Procedure Details</bold>
</p>
        <p>Pleurodesis may be performed through a 28- to 32-French gauge chest tube or a pigtail catheter in a premedicated patient provided adequate analgesia.<xref ref-type="bibr" rid="article-130747.r172">[172]</xref> In practice, some clinicians recommend that nonsteroidal anti-inflammatory drugs, selective cyclooxygenase-2 inhibitors, and corticosteroids be avoided 48 hours before and 5 days following the procedure to avoid interference with the fibrotic pleural response to the sclerosant.<xref ref-type="bibr" rid="article-130747.r173">[173]</xref> Greater than 150 mL/day aspirate, radiograph demonstrating residual fluid, suspicion of pleural infection, and a lack of informed consent are contraindications to the procedure. Lung inflation should be confirmed by auscultation and chest radiograph.</p>
        <p>Specific risks of bleeding, pain, and procedure failure rates (approaching 20%) should be explained to the patient. The risk of acute respiratory distress syndrome using talc as a sclerosing agent is less than 1%.<xref ref-type="bibr" rid="article-130747.r174">[174]</xref> A combination of lidocaine and a sclerosing agent is instilled through the chest tube or indwelling pleural catheter into the pleural space. The dose of lidocaine in a single patient should not exceed 3 mg/kg, and altered pharmacokinetics should keep in mind the sarcopenic status of the patient with advanced cancer. When using talc, the solution must be thoroughly agitated for proper dissolution. Further movement of the container or syringe must be avoided once the slurry is prepared to prevent talc particle precipitation.<xref ref-type="bibr" rid="article-130747.r175">[175]</xref></p>
        <p>The catheter should be flushed with normal saline after the slurry has been installed.<xref ref-type="bibr" rid="article-130747.r176">[176]</xref> Recommendations on patient rotation for up to 1 hour to ensure uniform distribution of the sclerosant vary among authorities, with caution advised by some. Variability exists in the recommended withholding time of the sclerosant mixture in the pleural space after drain clamping, with durations ranging from 1 to 6 hours.<xref ref-type="bibr" rid="article-130747.r177">[177]</xref><xref ref-type="bibr" rid="article-130747.r178">[178]</xref> The drain should be unclamped and removed 24 to 48 hours after ensuring lung reexpansion and pleural cavity drainage.</p>
        <p>Respiratory rate, temperature, pain intensity, pulse rate, oxygen saturation, blood pressure, and characteristics of the fluid drained should be monitored. A postprocedure chest radiograph should be performed to rule out pneumothorax and confirm pleural fluid eradication. Drain or catheter may be removed after 24 to 48 hours of sclerosant administration and following confirmation of a normal chest radiograph, decrease in pleural fluid drainage to less than 100 mL, and absence of air leak.<xref ref-type="bibr" rid="article-130747.r179">[179]</xref></p>
        <p>Patients in the recently concluded TAPPS trial were discharged following a pleurodesis procedure (talc slurry or thoracoscopic talc insufflation) when the total pleural fluid drain output was less than 250 mL daily.<xref ref-type="bibr" rid="article-130747.r180">[180]</xref> Although prophylactic radiotherapy has no role in preventing procedure tract metastases, local palliative radiotherapy may be indicated in the presence of painful nodules in patients with malignant pleural mesothelioma.<xref ref-type="bibr" rid="article-130747.r181">[181]</xref></p>
        <p>Pleurodesis efficacy is classified into complete response (no pleural fluid reaccumulation), partial response (residual fluid without symptomatic reaccumulation needing further drainage for up to 6 months), and failure (requiring additional procedures, depending on patient survival and follow-up).<xref ref-type="bibr" rid="article-130747.r182">[182]</xref> Chest pain has been reported as the most common complication after pleurodesis, followed by fever. Acute respiratory distress syndrome with talc and visual loss due to large quantities of povidone-iodine have also been reported.<xref ref-type="bibr" rid="article-130747.r183">[183]</xref> Using povidone-iodine as a sclerosant is indicated when talc is unavailable or contraindicated. Thoracoscopic talc poudrage was introduced by Bethune in 1934 as a method of producing adhesiolysis before lobectomy. Chambers reported using thoracoscopic talc slurry in humans for the first time.<xref ref-type="bibr" rid="article-130747.r184">[184]</xref><xref ref-type="bibr" rid="article-130747.r185">[185]</xref></p>
        <p>Contraindications to talc pleurodesis for recurrent pleural effusion may include pregnancy, prior intrapleural procedures or thoracic irradiation, recent changes in systemic therapy within the past 2 months, and chylous or bilateral pleural effusions. Talc&#x000a0;may be administered in the pleural cavity prepared as a slurry, admixed with normal saline, or insufflated in a powdered form via a medical thoracoscopic procedure (single port of entry).<xref ref-type="bibr" rid="article-130747.r186">[186]</xref>&#x000a0; Medical-grade talc has been shown to activate pleural mesothelial cells to produce significantly higher essential fibroblast growth factor (also basic fibroblast growth factor or bFGF) levels. BFGF has been hypothesized to be the chemical mediator responsible for pleurodesis <xref ref-type="bibr" rid="article-130747.r187">[187]</xref>. Thoracoscopic talc insufflation (TTI) enables direct pleural visualization, adhesiolysis, and treatment of loculated pleural effusions.<xref ref-type="bibr" rid="article-130747.r188">[188]</xref> The procedure is effective for managing cases with previous ipsilateral surgery, attempted adhesiolysis, and trapped lung. However, TTI has been associated with a higher incidence of respiratory complications such as atelectasis, pneumonia, and respiratory failure.</p>
        <p>Risk factors for a failed pleurodesis include a history of prior irradiation and a chest tube in place for more than 10 days.<xref ref-type="bibr" rid="article-130747.r189">[189]</xref> Underlying causes for a failure of the procedure include uneven distribution of the agent within the lung, failure of the lung to reexpand following the procedure, and high tumor burden with low fluid pH. High tumor burden may be defined as having multiple pleural nodules on all aspects of the visceral and parietal pleura and adherence of the lobes with themselves and the parietal pleura. Prior thoracic irradiation might also increase the risk of developing a pleurocutaneous fistula.<xref ref-type="bibr" rid="article-130747.r190">[190]</xref>&#x000a0;</p>
        <p>The recently completed TAPPS trial found no differences between TTI and bedside chest drain talc slurry procedures in terms of pleurodesis failure at 90 days post-randomization. The trial suggests definitive evidence of their equivalence, as no significant differences were observed in secondary outcomes, including pleurodesis failure up to the 180-day visit, mortality, hospital stay duration, radiological effusion clearance, and patient-reported outcomes.<xref ref-type="bibr" rid="article-130747.r191">[191]</xref> Talc poudrage is less cost-effective than talc slurry. Another potential drawback of TTI would be the inability to perform the procedure safely under local anesthetic guidance in patients with advanced cancer considered to be frail.<xref ref-type="bibr" rid="article-130747.r192">[192]</xref>&#x000a0;</p>
        <p><bold>Indwelling Pleural Catheter</bold>
<bold>Placement</bold></p>
        <p>Inserting an indwelling pleural catheter (IPC) is safe and effective for draining smaller or loculated recurrent pleural effusions.<xref ref-type="bibr" rid="article-130747.r193">[193]</xref> The increased use of bedside imaging has bolstered its viability for alleviating respiratory symptoms.<xref ref-type="bibr" rid="article-130747.r194">[194]</xref> This procedure is well-tolerated by patients with advanced cancer. While the presence of a catheter induces inflammation and promotes autopleurodesis (between the visceral and parietal pleura), rapid lung reexpansion is facilitated by the negative suction pressure from vacuum bottles.<xref ref-type="bibr" rid="article-130747.r195">[195]</xref>&#x000a0;</p>
        <p>Bertolaccini et al pointed out the lower complication rates and advocated early implantation of IPCs over repeated needle thoracentesis.<xref ref-type="bibr" rid="article-130747.r196">[196]</xref> The AMPLE and ASAP 2 trials have demonstrated higher rates and shorter times to autopleurodesis in those treated with an IPC and aggressive drainage than those treated with an IPC and alternate-day drainage.<xref ref-type="bibr" rid="article-130747.r197">[197]</xref> Malignant pleural effusion is unsuitable for pleurodesis. Recurrent pleural effusions after pleurodesis and trapped lung have been considered conventional indications for inserting an IPC. Multiloculated effusions, infection at the insertion site, malignant skin infiltration at the insertion site, and coagulopathy are potential contraindications to IPC insertion. Pleural empyema, accidental dislodgement, drain malfunction, and spontaneous fracture have been reported as possible complications.</p>
        <p><bold>Comparison of Various Treatment Modalities</bold>&#x000a0;</p>
        <p>The meta-analysis by Sivakumar et al found that TTI, talc slurry, and IPCs similarly improve health-related quality-of-life parameters over 12 weeks, but long-term data is lacking due to high attrition rates. The authors concluded that the lack of randomized control trials in this setting mars the evidence of the comparative efficacy of these 3 procedures.<xref ref-type="bibr" rid="article-130747.r198">[198]</xref>&#x000a0;Successful outpatient rapid pleurodesis has been demonstrated using thoracoscopy and talc slurry with the insertion of a tunneled pleural catheter in the same setting. A prospective randomized control trial conducted by Reddy et al revealed that patients undergoing rapid pleurodesis with a combination of procedures may be discharged on the day&#x000a0;of&#x000a0;those procedures. A trial by Olfert et al also demonstrated IPC as a cost-effective treatment method.<xref ref-type="bibr" rid="article-130747.r199">[199]</xref> Bhatnagar et al reported a median time to achieve pleurodesis of 4 days using drug-eluting IPCs<italic toggle="yes">.</italic></p>
        <p>The results of the ongoing SWIFT trial are expected to provide further insight into the efficacy and safety profile of drug-eluting pleural catheters. The sclerosant used in these trials consists of a slow-release coating of silver nitrate.<xref ref-type="bibr" rid="article-130747.r200">[200]</xref> Dipper et al's Cochrane network meta-analysis indicated that 20 out of 100 patients required a repeat procedure post-talc pleurodesis, 19 out of 100 post-talc slurry, and 52 out of 100 after bleomycin treatment. The group&#x02019;s findings suggest that talc poudrage and talc slurry are superior to other methods for pleurodesis. The group also identified catheter site infection (cellulitis) and pleural infection as potential complications of IPC insertion. This network meta-analysis supports bedside-graded talc as the sclerosant of choice, given the years of experience with this modality. The authors opine that searching for a single ideal procedure for managing a complex problem may prove futile.<xref ref-type="bibr" rid="article-130747.r201">[201]</xref> considering patient preferences and practical issues in the real-life setting (eg, patient and family experience) may represent a sensible way forward.&#x000a0;</p>
        <p>
<bold>Special Scenarios</bold>
</p>
        <p>Special circumstances influence treatment choices. Careful consideration of these situations is crucial to improve patient outcomes.</p>
        <p><bold>Trapped lung</bold>&#x000a0;</p>
        <p>"Trapped lung" describes a form of advanced lung pathology, often in patients with a history of molecular pathological epidemiology (MPE0, characterized by the lung's inability to expand fully, resulting in the failure of the visceral pleura to adhere to the parietal pleura and leaving a residual cavity. The term "lung entrapment" refers to the lung's failure to reexpand due to an active pleural process and visceral pleural peel formation. In contrast, "trapped lung" denotes a similar condition that occurred in the past. Growth factor production increases fibroblast proliferation and collagen production, leading to fibrotic reorganization of the visceral pleura.<xref ref-type="bibr" rid="article-130747.r202">[202]</xref> A ventilation-perfusion mismatch due to the altered respiratory ventilatory dynamics leads to dyspnea, potentially adversely impacting the quality of life.<xref ref-type="bibr" rid="article-130747.r203">[203]</xref>&#x000a0;</p>
        <p>A trapped lung may result from pleural thickening that limits the visceral pleura's movement, potentially leading to a fibrinous exudate around the lung. Potential causes include direct malignant cell infiltration, fibrosis within the visceral pleura, pleural carcinomatosis, radiation-induced fibrosis, and proximal endobronchial obstruction causing distal lung collapse or chronic atelectasis with a concurrent malignant or paramalignant pleural effusion. The radiological finding of pneumothorax <italic toggle="yes">ex vacuo,</italic> which has been characterized by the failure of the lung to expand after pleural fluid drainage, may represent a trapped lung. Thoracic ultrasonography may help differentiate between pleural thickening, pleural fluid, and consolidation.<xref ref-type="bibr" rid="article-130747.r204">[204]</xref> Non expandable lung/unexpanded lung (NEL/UL) is a clinical entity defined by the apposition of the lung to less than 25% to 50% of the chest wall. This entity represents a potentially reversible condition that may revert to its original state with the institution of antitumor therapy. NEL may also represent a scenario where the lung, unable to reexpand due to a prolonged collection period, can fully reexpand after the effusion is drained.<xref ref-type="bibr" rid="article-130747.r205">[205]</xref>&#x000a0;</p>
        <p>All NEL cases do not meet the criteria for a trapped lung. Patients with a NEL have been shown to develop autopleurodesis using an IPC.<xref ref-type="bibr" rid="article-130747.r206">[206]</xref> Diagnosis is made upon clinical examination. Occurrence of severe dull or sharp pleuritic chest pain and cough during thoracentesis and thoracic ultrasonography has been used to diagnose trapped lung. Though video-assisted thoracoscopy has been used as a definitive diagnostic modality, the measurement of pleural fluid elastance using pleural manometry also represents a promising approach.</p>
        <p>Pleural fluid elastance is measured by the decrease in pleural fluid pressures in cm H2O after 500 mL of fluid is removed by thoracentesis. In a trapped lung with MPE, the pleural pressure is low and tends to drop significantly as fluid is removed. Pleural fluid elastance of more than 14.5 cm H2O per liter has been shown to represent a pleural space mechanical abnormality.<xref ref-type="bibr" rid="article-130747.r207">[207]</xref> The following strategies&#x000a0;are considered potentially beneficial in managing trapped lungs: IPC, surgical pleurectomy or decortication, pleuroperitoneal shunting, and intrapleural fibrinolysis.</p>
        <p>
<bold>Persistent air leaks&#x000a0;</bold>
</p>
        <p>The possibility of developing pneumothorax after ultrasound-guided thoracentesis is slight (3%-4%) but significant. A small fraction of individuals who develop pneumothorax will require chest tube insertion.<xref ref-type="bibr" rid="article-130747.r208">[208]</xref> An air leak manifests as a collection of air bubbles in the drainage bag connected to the chest drain.<xref ref-type="bibr" rid="article-130747.r209">[209]</xref> A persistent air leak is defined as one that exists for more than 5 to 7 days following chest tube insertion.<xref ref-type="bibr" rid="article-130747.r210">[210]</xref> Communication between the sterile pleural space and the tracheobronchial tree in the form of alveolar pleural fistulous communication or bronchopleural fistula may be the underlying cause.</p>
        <p>The American College of Chest Physicians has advised a period of conservative management for 4 days, during which the fistulous communication is expected to close on its own.<xref ref-type="bibr" rid="article-130747.r211">[211]</xref> A thoracic surgery opinion with consideration of pleurodesis may be indicated if watchful management fails. Minimally invasive approaches may be considered for nonsurgical candidates and individuals who refuse surgical management. Autologous blood patch pleurodesis, Heimlich valves, endobronchial valves, tissue adhesives, and occlusive devices can also be used to obliterate communication.<xref ref-type="bibr" rid="article-130747.r212">[212]</xref> A definitive surgical approach or open thoracotomy with chemical or mechanical pleurodesis or pleurectomy has been proposed as the definitive surgical approach.</p>
        <p>
<bold>Septated pleural effusion</bold>
</p>
        <p>Fibrin-rich effusion fluids can lead to the development of pockets within the effusion. Significant adhesions have been demonstrated in almost 40% of patients on thoracoscopy by Bielsa et al.<xref ref-type="bibr" rid="article-130747.r213">[213]</xref> Significant adhesions are defined as those that obstruct more than one-third of the field of view in thoracoscopy.<xref ref-type="bibr" rid="article-130747.r214">[214]</xref> In patients undergoing chest drain insertion, an increasing number of septations have been associated with the failure to achieve adequate relief of dyspnea.<xref ref-type="bibr" rid="article-130747.r215">[215]</xref></p>
        <p>Septations must be distinguished from vascularized adhesions, which may develop when fibrinous septations are infiltrated with fibroblasts and organized with collagen fibrils. Despite their interchangeable use in literature, these terms need clear definitions to emphasize their impact on prognosis. An ultrasound-based grading system characterizes the severity of septations or organized adhesions based on their nature and number.</p>
        <p>Significant adhesions may cause failure of an effusion to drain effectively. Fibrous septations and adhesions may be differentiated based on thoracoscopy. While fibrinous adhesions can be divided easily, dense organized adhesions usually show the presence of blood vessels on thoracoscopy.<xref ref-type="bibr" rid="article-130747.r216">[216]</xref> A CT scan does not help visualize septations directly. However, indirect evidence of septations, such as air pockets, may be seen. Adhesiolysis with the intrapleural instillation of fibrinolytic has been used to facilitate drainage of septated pleural effusion.<xref ref-type="bibr" rid="article-130747.r217">[217]</xref></p>
        <p>The TIME 3 trial demonstrated no clinically significant improvement in dyspnea or time to pleurodesis failure rates over 1 year with intrapleural streptokinase instillation in nondraining malignant septated pleural effusions. No significant differences were reported between the urokinase and placebo groups in quality of life parameters at any time during the study. The study has been critiqued for the possible impact of fibrinolytic agents on the efficacy of repeat procedures, but these concerns remain unproven. Given the short half-life of these agents, any substantial impact on the efficacy of repeat drainage and pleurodesis procedures is not expected.</p>
        <p>Another concern with fibrinolytic use remains the possibility of bleeding into the pleural fluid, which has been attributed to the presence of friable vessels within the hemorrhagic fluid due to neoangiogenesis. However, the risk of bleeding has remained minimal with the concomitant use of an IPC and does not seem to represent a substantial concern. The authors conclude that intrapleural thrombolytic agents improve lung reexpansion but do not increase successful pleurodesis rates. The persistent dyspnea in these patients has led to reconsidering the use of drainage catheters in this context. Alternative methods for palliation of breathlessness in advanced cancer have been advocated.<xref ref-type="bibr" rid="article-130747.r218">[218]</xref></p>
        <p>
<bold>Malignant eosinophilic pleural effusion</bold>
</p>
        <p>Malignant eosinophilic pleural effusion (MEPE) is defined as having more than 10% of eosinophils in the differential white blood cell count in the first thoracentesis exudative effusion and histological confirmation of malignancy. Repeated thoracentesis, blood or air in the pleural space, and drug interactions may be confounding factors that must be ruled out before a diagnosis of MEPE can be made conclusively. Lung cancer (ie, non-small cell adenocarcinoma and squamous cell carcinoma), metastasis to the lung, non-Hodgkin lymphoma, and dysgerminoma are the common etiologies underlying MEPE.<xref ref-type="bibr" rid="article-130747.r219">[219]</xref>&#x000a0;</p>
        <p>MEPE&#x02019;s pathogenesis involves 2 steps: accumulation and migration. Accumulation of eosinophils occurs due to increased production within the bone marrow. Migration is promoted by the firm cytoadherence of these eosinophils to endothelial cells. Increased production of cytokines such as interleukins 33, 4, and 5, which have been shown to have chemoattractant properties that aid in eosinophilic migration, has been reported in patients with non-small cell lung cancer.<xref ref-type="bibr" rid="article-130747.r220">[220]</xref> Tumor-homing eosinophils are also shown to secrete chemokines, stimulating T-cell expansion within the tumor microenvironment. Eosinophils have been shown to enhance the maturation of dendritic cells in the tumor microenvironment, which overcomes tumor tolerance and has been associated with a better prognosis.<xref ref-type="bibr" rid="article-130747.r221">[221]</xref>&#x000a0;Though cancer-directed therapies can control pleural fluid formation in small-cell lung cancer, strategies that improve survival are still needed. Measures to palliate symptoms are similar to the ones employed for non-eosinophilic malignant pleural effusion. The percentage of eosinophils may represent an important marker of prognosis, and further research on this topic has been advocated.&#x000a0;</p>
        <p>
<bold>Hemorrhagic malignant pleural effusion</bold>
</p>
        <p>Hemorrhagic malignant pleural effusion (HMPE) occurs with a frequency of 47% to 50%. HMPE is usually characterized by a pronounced degree of dyspnea, higher chest pain incidence, general physical deterioration, cooccurrence with large effusion, and thickening with parietal pleural effusion. Cytological analysis usually reveals an increased percentage of malignant cells in the pleural fluid. Thickened parietal pleura with hemorrhagic nodules may be visualized on thoracoscopy. Talc pleurodesis and thoracoscopic talc poudrage are less effective. HMPE is usually associated with poor survival and higher rates of pleurodesis.<xref ref-type="bibr" rid="article-130747.r222">[222]</xref></p>
        <p>
<bold>Palliative symptom-directed management of dyspnea in advanced cancer&#x000a0;</bold>
</p>
        <p>Dyspnea has been defined as a subjective experience of breathing discomfort that consists of qualitatively distinct sensations of variable intensity.<xref ref-type="bibr" rid="article-130747.r223">[223]</xref> Ambrosino et al have suggested that differences in language, culture, race, and gender can influence the subjective experience of breathlessness.<xref ref-type="bibr" rid="article-130747.r224">[224]</xref> Refractory breathlessness has been defined as breathlessness that persists despite optimal treatment of the underlying condition and has been associated with a shortened life expectancy.<xref ref-type="bibr" rid="article-130747.r225">[225]</xref> Refractory breathlessness is especially frightening for patients and families and results in the use of acute hospital services.<xref ref-type="bibr" rid="article-130747.r226">[226]</xref> The term "chronic breathlessness syndrome" has been suggested to delineate a syndrome that consists of breathlessness that persists despite optimal management of the underlying pathophysiology.<xref ref-type="bibr" rid="article-130747.r227">[227]</xref></p>
        <p>The feeling of breathlessness in advanced cancer has been explained by a mismatch between afferent sensory information sent by the afferent receptors and the respiratory motor command from the cortex and brainstem.<xref ref-type="bibr" rid="article-130747.r228">[228]</xref> The biopsychosocial model and the breathing, thinking, and functioning models have been used to explain the physiopathology of dyspnea in advanced cancer.<xref ref-type="bibr" rid="article-130747.r229">[229]</xref> Notably, breathlessness arises from interactions among physiological, psychological, social, and environmental factors. The sensation of dyspnea can induce secondary physiological and behavioral responses.<xref ref-type="bibr" rid="article-130747.r230">[230]</xref> The degree of physiological impairment, as&#x000a0;indicated by hypoxemia or a low forced expiratory volume in 1 second, weakly correlates with a person's subjective sensation of breathlessness, complicating treatment efforts.<xref ref-type="bibr" rid="article-130747.r231">[231]</xref>&#x000a0;</p>
        <p>Patient-reported outcomes are considered the gold standard in the assessment of breathlessness.<xref ref-type="bibr" rid="article-130747.r232">[232]</xref> While unidimensional tools such as numerical rating and visual analog scales may be used, assessing the subjective experience of the patient and its impact on functional outcomes is of utmost importance.<xref ref-type="bibr" rid="article-130747.r233">[233]</xref> The London Chest Activities of Daily Living Scale has been shown to effectively measure the impact of breathlessness on functional and social activity in patients with refractory breathlessness in advanced disease.<xref ref-type="bibr" rid="article-130747.r234">[234]</xref> Episodic breathlessness should be identified, characterized as a separate entity, and managed according to prescribed guidelines.<xref ref-type="bibr" rid="article-130747.r235">[235]</xref></p>
        <p>The management of chronic breathlessness syndrome usually requires specialist palliative medicine input. Palliative interventions, including pharmacological and nonpharmacological management, are provided through visits across many settings. Nonpharmacological interventions may be recommended for patients experiencing breathlessness due to advanced cancer or MPE resistant to other treatments.</p>
        <p>Nonpharmacological interventions include using a handheld fan for facial cooling, practicing breathing retraining, trying mobility aids, promoting self-management with activity pacing and relaxation techniques, participating in exercise-based rehabilitation, and exploring complementary and alternative treatments. Among pharmacological options, only opioids and oxygen are helpful. Correct opioid dosing is essential, and doses between 10 and 30 mg of extended-release morphine sulfate have been used. A rescue dose or immediate-release morphine of about 1/6 of the patient's total daily morphine dose may be considered for exacerbation of breathlessness if required.</p>
        <p>Supplemental oxygen (palliative oxygen therapy) is indicated in patients with chronic severe hypoxemia (partial pressure of oxygen or PaO2 &#x0003c;7.3 kPa, corresponding to an oxygen saturation level &#x0003e;88%).<xref ref-type="bibr" rid="article-130747.r236">[236]</xref> Evidence from clinical trials does not support using benzodiazepines for the relief of breathlessness. These medications are not advised&#x000a0;as first-line interventions.<xref ref-type="bibr" rid="article-130747.r237">[237]</xref> Benzodiazepines may be used to alleviate anxiety associated with air hunger as second or third-line treatments when opioids are not effective. Steroids have been advised to manage breathlessness refractory to other treatment options.<xref ref-type="bibr" rid="article-130747.r238">[238]</xref>&#x000a0;</p>
        <p>Noninvasive ventilation may improve oxygenation and hypoventilation and support chest wall muscles.<xref ref-type="bibr" rid="article-130747.r226">[226]</xref> A trial of noninvasive ventilation should be considered in chronic severe breathlessness, especially in patients with acute hypercapnic respiratory failure. Refractory breathlessness is also recognized as an indication to provide palliative sedation at the end of life.<xref ref-type="bibr" rid="article-130747.r239">[239]</xref> The use of palliative sedation for refractory symptoms at the end of life can be justified by the ethical doctrine of double effect, developed by the Roman Catholic church,&#x000a0;originating back to the Salamanticensis theologians of the 16th and 17th centuries.<xref ref-type="bibr" rid="article-130747.r240">[240]</xref></p>
        <p>
<bold>Caregiver distress</bold>
</p>
        <p>A substantial body of data demonstrates that carers of individuals with chronic breathlessness experience profound anxiety, isolation, exhaustion, and poor sleep. This distress is heightened when they witness their loved ones having an episode of breathlessness. A feeling of powerless (inability to help) and exhaustion from the extra physical work adds to the genesis and propagation of caregiver distress. Psychoeducation and the provision of psychological support may be necessary. Recognition and acknowledgment of symptoms are practical first steps in managing caregiver distress.<xref ref-type="bibr" rid="article-130747.r241">[241]</xref>&#x000a0;The phenomenon of compassion fatigue (burnout and secondary traumatic stress) in healthcare professionals involved in caring for patients with terminal life-limiting illnesses also needs to be recognized.<xref ref-type="bibr" rid="article-130747.r242">[242]</xref> Preparatory grief and existential suffering in patients with advanced cancer near the end of life often require intervention from a specialist palliative care team.<xref ref-type="bibr" rid="article-130747.r243">[243]</xref></p>
      </sec>
      <sec id="article-130747.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Clinical differential diagnoses</bold>
</p>
        <p>These conditions include raised hemidiaphragm (ie, due to phrenic nerve palsy or liver enlargement), pleural thickening (secondary to previous tuberculosis, empyema), plaques, consolidation, and lobar collapse.</p>
        <p>
<bold>Radiological differential diagnoses</bold>
</p>
        <p>These conditions include pleural thickening, benign and malignant plaques, pseudo-plaques, and inferior pulmonary ligament. Pseudo-plaques are defined as plaque-like lung opacities formed by small nodules contiguous with the visceral pleura. These plaques are formed by small coalescent nodules, commonly seen in sarcoidosis, coal workers' pneumoconiosis, and silicosis.&#x000a0;</p>
        <p><bold>Histopathological differential diagnoses</bold>&#x000a0;</p>
        <p>Nonspecific pleuritis arises from cytology-negative exudative pleural effusion without a definable etiology after histopathological analysis. Possible etiologies may include radiation- and chemotherapy-induced pleuritis. From 3% to 12% of patients with nonspecific pleuritis are diagnosed with a pleural malignancy upon regular surveillance.</p>
        <p>
<bold>Other types of effusion</bold>
</p>
        <p>Paramalignant pleural effusion and MPE must be differentiated due to their distinct prognostic implications. Paramalignant effusions may result from various pathophysiological processes, including tumor-related obstruction, thoracic duct obstruction, pulmonary embolism, and hypoalbuminemia causing low colloidal osmotic pressure. Superior vena cava obstruction may occur as a late complication of mediastinal radiotherapy or due to increased venous pressures from local tumor effects. Treatment-related effusions can arise from radiotherapy, conventional chemotherapy (eg, bleomycin, procarbazine, cyclophosphamide, and methotrexate), targeted therapy (eg, dasatinib), and immunotherapy. Other causes of pleural fluid accumulation include congestive heart failure, hepatic decompensation, and renal failure.</p>
      </sec>
      <sec id="article-130747.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The LENT, modified LENT, and PROMISE scores have been developed to predict MPE-related outcomes <xref ref-type="bibr" rid="article-130747.r244">[244]</xref>. A lack of inclusion of newer targeted therapies within its purview has been pointed out as a potential drawback of using older prognostication systems.<xref ref-type="bibr" rid="article-130747.r245">[245]</xref>&#x000a0;</p>
        <p>The LENT score consists of the following parameters: pleural fluid lactate dehydrogenase, Eastern Cooperative Oncology Group performance status, neutrophil-to-lymphocyte ratio, and tumor type. The PROMISE score uses a more diverse range of biomarkers to predict the 3-month mortality and success rate of pleurodesis in this cohort of patients.<xref ref-type="bibr" rid="article-130747.r246">[246]</xref> Protein expression levels of tissue inhibitors of metalloproteases-1, cadherin-1, platelet-derived growth factor, vascular endothelial growth factor, and interleukin-4 are predicted biomarkers in the PROMISE model.<xref ref-type="bibr" rid="article-130747.r247">[247]</xref>&#x000a0;</p>
        <p>The SELECT score uses the following markers to predict 90-day survival in these patients: sex, Eastern Cooperative Oncology Group, leucocyte count, epidermal growth factor receptor status, chemotherapy, and primary tumor type. The SELECT score has been shown to perform better than the LENT and PROMISE scores in prognosticating survival. The modified LENT score is comparable&#x000a0;to the SELECT score in prognosticating survival.</p>
        <p>Prognostication individualization in this domain is also suggested, highlighting the need for systems incorporating patient preferences, newer targeted therapy, immunotherapy approaches, and symptom burden within their purview. Prognostication in advanced disease may involve using various tools such as the PPI, which consists of the palliative performance scale, edema, dyspnea, reduced oral intake, and delirium. A score of more than 4.5 is usually associated with a survival of fewer than 6 weeks. Chest tube drainage, chemical pleurodesis, and thoracoscopy-guided talc drainage have been recommended over repeated procedures due to the risk of developing adhesions with the performance of repeat thoracentesis.<xref ref-type="bibr" rid="article-130747.r248">[248]</xref>&#x000a0;Having an actionable mutation in non-small cell lung cancer with MPE poses a similar recurrence risk to having no actionable mutation. In a study by Scwalk et al, larger pleural effusion size, pleural fluid lactate dehydrogenase, and positive cytological examination results have been associated with a higher recurrence rate of pleural effusions.<xref ref-type="bibr" rid="article-130747.r249">[249]</xref></p>
      </sec>
      <sec id="article-130747.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Trapped lung, persistent air leaks after chest tube insertion (for iatrogenic pneumothorax), and septated effusion are all potential MPE complications. Treatment complications have been mentioned in other parts of this activity, such as complications associated with procedures used for draining pleural fluid (ie, thoracoscopic talc poudrage, talc slurry, tunneled catheter insertion, and pleurodesis). MPE does not have a cure, and symptom palliation is the primary treatment goal. The financial challenges of repeated procedures for families already burdened by the costs of cancer treatment must be recognized.<xref ref-type="bibr" rid="article-130747.r250">[250]</xref></p>
      </sec>
      <sec id="article-130747.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The American Thoracic Society has developed an important monograph to educate patients about the indications, risks, care, and removal of indwelling catheters to treat MPE. Regular follow-up with healthcare professionals is recommended.<xref ref-type="bibr" rid="article-130747.r251">[251]</xref></p>
      </sec>
      <sec id="article-130747.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Tumor clonal evolution owing to pharmacological pressure to anticancer treatment has been shown to underlie the differences in mutations in the primary tumor and pleural metastases. Personalized MPE therapy based on the actionable mutation discovered in the malignant pleural cells may represent the future of definitive treatment. Crizotinib effectively reduces the amount of pleural effluent in a patient with lung adenocarcinoma with ALK mutation by Sun et al.<xref ref-type="bibr" rid="article-130747.r252">[252]</xref>&#x000a0;The utility of intrapleural immune stimulants is also being explored as a potential antitumor and sclerosant treatment. Ren et al have demonstrated increased survival in patients undergoing pleurodesis with a <italic toggle="yes">Staphylococcus aureus</italic> bioproduct mixture due to its immune-stimulating effect on T-cells, which might predispose to tumor cell apoptosis in malignant mesothelioma.<xref ref-type="bibr" rid="article-130747.r253">[253]</xref></p>
      </sec>
      <sec id="article-130747.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The interprofessional approach is essential to MPE management.&#x000a0;The treatment of medical issues in advanced cancer may play a critical role in improving the patient's survival and significantly impacting quality of life. Dyspnea is one of the key symptoms that has been shown to substantially affect the quality of life of patients with advanced cancer.</p>
        <p>The correctable causes of breathlessness must be treated before proceeding to pharmacological measures that decrease the patient's perception of discomfort due to breathlessness. Treatment aggressiveness is a contentious but essential region that requires family participation. Medical oncologists, respiratory medicine physicians, surgical oncologists, and palliative medicine experts may deliver therapeutic interventions for managing MPE.</p>
        <p>Managing pleural effusion in patients with advanced cancer at the end of life is a challenge that demands another look at the conventional role of a palliative medicine consult. Patients with advanced cancer, with a unique set of physical (medical and surgical), psychological, social, and spiritual issues, present unique inpatient admission challenges in the palliative medicine ward. The European Society of Medical Oncology has proposed using patient-centered care to encompass palliative and supportive care provision. The Society&#x02019;s definition of the patient-centered approach includes assessment, monitoring, interventions, and management of cancer-related symptoms and anticancer treatment-related complications. These guidelines remain the only official guidelines that acknowledge the role of the supportive and palliative medicine expert in directly managing this medical condition.</p>
      </sec>
      <sec id="article-130747.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=130747&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=130747">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/malignant-pleural-effusion/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=130747">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/130747/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=130747">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-130747.s16">
        <title>References</title>
        <ref id="article-130747.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>McPhillips</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Breen</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Malignant pleural effusion.</article-title>
            <source>QJM</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>107</volume>
            <issue>3</issue>
            <fpage>179</fpage>
            <page-range>179-84</page-range>
            <pub-id pub-id-type="pmid">24368856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wrona</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jassem</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[The new TNM classification in lung cancer].</article-title>
            <source>Pneumonol Alergol Pol</source>
            <year>2010</year>
            <volume>78</volume>
            <issue>6</issue>
            <fpage>407</fpage>
            <page-range>407-17</page-range>
            <pub-id pub-id-type="pmid">21077033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Krasna</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>278</fpage>
            <page-range>278-84</page-range>
            <pub-id pub-id-type="pmid">12118789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uzbeck</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Sarkiss</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Morice</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Eapen</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Management of malignant pleural effusions.</article-title>
            <source>Adv Ther</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>334</fpage>
            <page-range>334-47</page-range>
            <pub-id pub-id-type="pmid">20544327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koegelenberg</surname>
                <given-names>CFN</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Irusen</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YCG</given-names>
              </name>
            </person-group>
            <article-title>Contemporary best practice in the management of malignant pleural effusion.</article-title>
            <source>Ther Adv Respir Dis</source>
            <year>2018</year>
            <season>Jan-Dec</season>
            <volume>12</volume>
            <fpage>1753466618785098</fpage>
            <pub-id pub-id-type="pmid">29952251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>The pathophysiology of pleural effusions.</article-title>
            <source>Annu Rev Med</source>
            <year>1990</year>
            <volume>41</volume>
            <fpage>7</fpage>
            <page-range>7-13</page-range>
            <pub-id pub-id-type="pmid">2184750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mordant</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Arame</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Legras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Le Pimpec Barthes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Riquet</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Pleural lymphatics and effusions].</article-title>
            <source>Rev Pneumol Clin</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-80</page-range>
            <pub-id pub-id-type="pmid">23523230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agalioti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Giannou</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Stathopoulos</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Pleural involvement in lung cancer.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>1021</fpage>
            <page-range>1021-30</page-range>
            <pub-id pub-id-type="pmid">26150915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrelet</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>[Management of malignant pleural effusions secondary to breast cancer].</article-title>
            <source>Rev Med Suisse Romande</source>
            <year>1980</year>
            <month>Sep</month>
            <volume>100</volume>
            <issue>9</issue>
            <fpage>787</fpage>
            <page-range>787-9</page-range>
            <pub-id pub-id-type="pmid">7455479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>D&#x000ed;az</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gil</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cicero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Rodr&#x000ed;guez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sueiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Etiology and prognostic significance of massive pleural effusions.</article-title>
            <source>Respir Med</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>99</volume>
            <issue>9</issue>
            <fpage>1183</fpage>
            <page-range>1183-7</page-range>
            <pub-id pub-id-type="pmid">16085221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalomenidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pleural effusions.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>254</fpage>
            <page-range>254-60</page-range>
            <pub-id pub-id-type="pmid">12806236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalomenidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of the eosinophilic pleural effusions.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>289</fpage>
            <page-range>289-93</page-range>
            <pub-id pub-id-type="pmid">15220754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexandrakis</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Passam</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Kyriakou</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bouros</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusions in hematologic malignancies.</article-title>
            <source>Chest</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>125</volume>
            <issue>4</issue>
            <fpage>1546</fpage>
            <page-range>1546-55</page-range>
            <pub-id pub-id-type="pmid">15078773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herrera Lara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Fabrellas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Juan Samper</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marco Buades</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andreu Lapiedra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pinilla Moreno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morales Su&#x000e1;rez-Varela</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.</article-title>
            <source>Lung</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>195</volume>
            <issue>5</issue>
            <fpage>653</fpage>
            <page-range>653-660</page-range>
            <pub-id pub-id-type="pmid">28656381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liew</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stride</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Trapped lung.</article-title>
            <source>Intern Med J</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <pub-id pub-id-type="pmid">22356497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Terrington</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Management of Septated Malignant Pleural Effusions.</article-title>
            <source>Curr Pulmonol Rep</source>
            <year>2018</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">29568725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Bibby</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Blyth</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Corcoran</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Edey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evison</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Fonseka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hallifax</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lawrie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Noorzad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Opstad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parsonage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stanton</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>S</given-names>
              </name>
              <collab>BTS Pleural Guideline Development Group</collab>
            </person-group>
            <article-title>British Thoracic Society Guideline for pleural disease.</article-title>
            <source>Thorax</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>78</volume>
            <issue>Suppl 3</issue>
            <fpage>s1</fpage>
            <page-range>s1-s42</page-range>
            <pub-id pub-id-type="pmid">37433578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonnelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bonifazi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pinelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bedawi</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Malignant pleural effusion: current understanding and therapeutic approach.</article-title>
            <source>Respir Res</source>
            <year>2024</year>
            <month>Jan</month>
            <day>19</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <pub-id pub-id-type="pmid">38243259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bibby</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Dorn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Janssen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Froudarakis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Subotic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Astoul</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Licht</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scherpereel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Cardillo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>ERS/EACTS statement on the management of malignant pleural effusions.</article-title>
            <source>Eur Respir J</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30054348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feller-Kopman</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>DeCamp</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Diekemper</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YCG</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Sterman</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Wahidi</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Balekian</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>198</volume>
            <issue>7</issue>
            <fpage>839</fpage>
            <page-range>839-849</page-range>
            <pub-id pub-id-type="pmid">30272503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zahid</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Routledge</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bill&#x000e8;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Scarci</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>What is the best treatment for malignant pleural effusions?</article-title>
            <source>Interact Cardiovasc Thorac Surg</source>
            <year>2011</year>
            <month>May</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>818</fpage>
            <page-range>818-23</page-range>
            <pub-id pub-id-type="pmid">21325469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murthy</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Katzman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sterman</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.</article-title>
            <source>Clin Respir J</source>
            <year>2019</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>272</fpage>
            <page-range>272-279</page-range>
            <pub-id pub-id-type="pmid">30810270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.</article-title>
            <source>Oncol Lett</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>3657</fpage>
            <page-range>3657-3662</page-range>
            <pub-id pub-id-type="pmid">28927127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradshaw</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mansfield</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peikert</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.</article-title>
            <source>Curr Oncol Rep</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>207</fpage>
            <page-range>207-16</page-range>
            <pub-id pub-id-type="pmid">23568600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yalcin</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Choong</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Eizenberg</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Anatomy and pathophysiology of the pleura and pleural space.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10, v</page-range>
            <pub-id pub-id-type="pmid">23206712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai-Fook</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Pleural mechanics and fluid exchange.</article-title>
            <source>Physiol Rev</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>84</volume>
            <issue>2</issue>
            <fpage>385</fpage>
            <page-range>385-410</page-range>
            <pub-id pub-id-type="pmid">15044678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noppen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Waele</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gucht</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>D'Haese</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gerlo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vincken</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Volume and cellular content of normal pleural fluid in humans examined by pleural lavage.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>162</volume>
            <issue>3 Pt 1</issue>
            <fpage>1023</fpage>
            <page-range>1023-6</page-range>
            <pub-id pub-id-type="pmid">10988124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stathopoulos</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Kalomenidis</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Malignant pleural effusion: tumor-host interactions unleashed.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2012</year>
            <month>Sep</month>
            <day>15</day>
            <volume>186</volume>
            <issue>6</issue>
            <fpage>487</fpage>
            <page-range>487-92</page-range>
            <pub-id pub-id-type="pmid">22652027</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Canales</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parra-Cuentas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wistuba</surname>
                <given-names>II</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Molecular Classification of Lung Cancer.</article-title>
            <source>Cancer Treat Res</source>
            <year>2016</year>
            <volume>170</volume>
            <fpage>25</fpage>
            <page-range>25-46</page-range>
            <pub-id pub-id-type="pmid">27535388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jantz</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Antony</surname>
                <given-names>VB</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of the pleura.</article-title>
            <source>Respiration</source>
            <year>2008</year>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-33</page-range>
            <pub-id pub-id-type="pmid">18332619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kami&#x00144;ska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Szczylik</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bielecka</surname>
                <given-names>ZF</given-names>
              </name>
              <name>
                <surname>Bartnik</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Porta</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Czarnecka</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>The role of the cell-cell interactions in cancer progression.</article-title>
            <source>J Cell Mol Med</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>283</fpage>
            <page-range>283-96</page-range>
            <pub-id pub-id-type="pmid">25598217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsu</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Soong</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>YF</given-names>
              </name>
            </person-group>
            <article-title>The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis.</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Dec</month>
            <day>11</day>
            <volume>9</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">33322487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agalioti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Giannou</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Krontira</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Kanellakis</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Kati</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vreka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pepe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lilis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zazara</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Nikolouli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Spiropoulou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Papadakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papadia</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Voulgaridis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harokopos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stamou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meiners</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eickelberg</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Snyder</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Antimisiaris</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Kardamakis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Marazioti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stathopoulos</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Mutant KRAS promotes malignant pleural effusion formation.</article-title>
            <source>Nat Commun</source>
            <year>2017</year>
            <month>May</month>
            <day>16</day>
            <volume>8</volume>
            <fpage>15205</fpage>
            <pub-id pub-id-type="pmid">28508873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skok</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hladnik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grm</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Crnjac</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Malignant Pleural Effusion and Its Current Management: A Review.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2019</year>
            <month>Aug</month>
            <day>15</day>
            <volume>55</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">31443309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eastwood</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Physiology of breathlessness associated with pleural effusions.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <page-range>338-45</page-range>
            <pub-id pub-id-type="pmid">25978627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguilera Garcia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Palkar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koenig</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Narasimhan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mayo</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Diaphragm Function and Pleural Pressures During Thoracentesis.</article-title>
            <source>Chest</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>157</volume>
            <issue>1</issue>
            <fpage>205</fpage>
            <page-range>205-211</page-range>
            <pub-id pub-id-type="pmid">31398347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaul</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Epelbaum</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Approach to the Diagnosis of Malignant Pleural Effusion.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>1099</fpage>
            <page-range>1099-1106</page-range>
            <pub-id pub-id-type="pmid">31216176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mizobuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hoshino</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Moriya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshino</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-30</page-range>
            <pub-id pub-id-type="pmid">21616674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Memon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Nam</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.</article-title>
            <source>J Clin Oncol</source>
            <year>2014</year>
            <month>Mar</month>
            <day>20</day>
            <volume>32</volume>
            <issue>9</issue>
            <fpage>960</fpage>
            <page-range>960-7</page-range>
            <pub-id pub-id-type="pmid">24550423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manac'h</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riquet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Medioni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Le Pimpec-Barthes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dujon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Danel</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>1088</fpage>
            <page-range>1088-93</page-range>
            <pub-id pub-id-type="pmid">11308141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Malignant pleural effusions because of lung cancer.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>356</fpage>
            <page-range>356-61</page-range>
            <pub-id pub-id-type="pmid">27055072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Neville</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Berrisford</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Antunes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>NJ</given-names>
              </name>
              <collab>BTS Pleural Disease Guideline Group</collab>
            </person-group>
            <article-title>Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.</article-title>
            <source>Thorax</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>65 Suppl 2</volume>
            <fpage>ii32</fpage>
            <page-range>ii32-40</page-range>
            <pub-id pub-id-type="pmid">20696691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Galen</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>van der Ploeg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Smorenburg</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in patients with breast cancer and malignant pleural effusion.</article-title>
            <source>Breast J</source>
            <year>2010</year>
            <season>Nov-Dec</season>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>675</fpage>
            <page-range>675-7</page-range>
            <pub-id pub-id-type="pmid">21070453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moghaddam</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rahmani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taheri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Desfuli</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid.</article-title>
            <source>Adv Biomed Res</source>
            <year>2012</year>
            <volume>1</volume>
            <fpage>29</fpage>
            <pub-id pub-id-type="pmid">23210088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sikora</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dworacki</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Trybus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Batura-Gabryel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zeromski</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions.</article-title>
            <source>Tumour Biol</source>
            <year>1998</year>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-204</page-range>
            <pub-id pub-id-type="pmid">9591046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Clinical implications of pleural effusions in ovarian cancer.</article-title>
            <source>Respirology</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>1060</fpage>
            <page-range>1060-7</page-range>
            <pub-id pub-id-type="pmid">22458298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ataseven</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chiva</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Harter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gonzalez-Martin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>du Bois</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited.</article-title>
            <source>Gynecol Oncol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>142</volume>
            <issue>3</issue>
            <fpage>597</fpage>
            <page-range>597-607</page-range>
            <pub-id pub-id-type="pmid">27335253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Ayyagari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bambery</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusions in non-Hodgkin's lymphoma. A cytomorphologic, cytochemical and immunologic study.</article-title>
            <source>Acta Cytol</source>
            <year>1987</year>
            <season>Mar-Apr</season>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-24</page-range>
            <pub-id pub-id-type="pmid">3548191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antony</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Loddenkemper</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Astoul</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boutin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goldstraw</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rodriguez Panadero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Management of malignant pleural effusions.</article-title>
            <source>Eur Respir J</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>402</fpage>
            <page-range>402-19</page-range>
            <pub-id pub-id-type="pmid">11529302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Serous effusions in malignant lymphomas: a review.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2006</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>335</fpage>
            <page-range>335-47</page-range>
            <pub-id pub-id-type="pmid">16604559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunter</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Dhakal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Voci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Constine</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusions in patients with Hodgkin lymphoma: clinical predictors and associations with outcome.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>55</volume>
            <issue>8</issue>
            <fpage>1822</fpage>
            <page-range>1822-6</page-range>
            <pub-id pub-id-type="pmid">24237578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bianchi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bianchi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Non-Hodgkin Lymphoma and Pleural Mesothelioma in a Person Exposed to Asbestos.</article-title>
            <source>Turk Patoloji Derg</source>
            <year>2018</year>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-193</page-range>
            <pub-id pub-id-type="pmid">28272659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez Panadero</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of malignant pleural mesothelioma.</article-title>
            <source>Arch Bronconeumol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>177</fpage>
            <page-range>177-84</page-range>
            <pub-id pub-id-type="pmid">25059587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puchalski</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Argento</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Araujo</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Oliva</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Rubinowitz</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Pisani</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Etiologies of bilateral pleural effusions.</article-title>
            <source>Respir Med</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>107</volume>
            <issue>2</issue>
            <fpage>284</fpage>
            <page-range>284-91</page-range>
            <pub-id pub-id-type="pmid">23219348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCarten</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nadel</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Shulkin</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.</article-title>
            <source>Pediatr Radiol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>49</volume>
            <issue>11</issue>
            <fpage>1545</fpage>
            <page-range>1545-1564</page-range>
            <pub-id pub-id-type="pmid">31620854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asciak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Malignant Pleural Effusion: From Diagnostics to Therapeutics.</article-title>
            <source>Clin Chest Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>181</fpage>
            <page-range>181-193</page-range>
            <pub-id pub-id-type="pmid">29433714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Son</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Seol</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Eom</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients: A multicenter retrospective study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2021</year>
            <month>May</month>
            <day>14</day>
            <volume>100</volume>
            <issue>19</issue>
            <fpage>e25748</fpage>
            <pub-id pub-id-type="pmid">34106603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diaz-Guzman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Budev</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of the physical examination in evaluating pleural effusion.</article-title>
            <source>Cleve Clin J Med</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>297</fpage>
            <page-range>297-303</page-range>
            <pub-id pub-id-type="pmid">18491436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elliott-Button</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nwulu</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Identification and Assessment of Breathlessness in Clinical Practice: A Systematic Review and Narrative Synthesis.</article-title>
            <source>J Pain Symptom Manage</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>724</fpage>
            <page-range>724-733.e19</page-range>
            <pub-id pub-id-type="pmid">31655187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janssens</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Breitenstein</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rochat</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fitting</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Does the 'oxygen cost diagram' reflect changes in six minute walking distance in follow up studies?</article-title>
            <source>Respir Med</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>11</issue>
            <fpage>810</fpage>
            <page-range>810-5</page-range>
            <pub-id pub-id-type="pmid">10603630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Close</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gillon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Molassiotis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Farquhar</surname>
                <given-names>MC</given-names>
              </name>
              <collab>Breathlessness Research Interest Group (BRIG)</collab>
            </person-group>
            <article-title>Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis.</article-title>
            <source>Eur Respir J</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>1861</fpage>
            <page-range>1861-4</page-range>
            <pub-id pub-id-type="pmid">26989107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanhoutte</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Faber</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>van Nes</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>van Doorn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>van Koningsveld</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cornblath</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>van der Kooi</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cats</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>van den Berg</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Notermans</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>van der Pol</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Hermans</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>van der Beek</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Gorson</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Eurelings</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Engelsman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boot</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lauria</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tennant</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Merkies</surname>
                <given-names>IS</given-names>
              </name>
              <collab>PeriNomS Study Group</collab>
            </person-group>
            <article-title>Modifying the Medical Research Council grading system through Rasch analyses.</article-title>
            <source>Brain</source>
            <year>2012</year>
            <month>May</month>
            <volume>135</volume>
            <issue>Pt 5</issue>
            <fpage>1639</fpage>
            <page-range>1639-49</page-range>
            <pub-id pub-id-type="pmid">22189568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutkowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rutkowski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wrzeciono</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Czech</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Szczegielniak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jastrz&#x00119;bski</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Short-Term Changes in Quality of Life in Patients with Advanced Lung Cancer during In-Hospital Exercise Training and Chemotherapy Treatment: A Randomized Controlled Trial.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Apr</month>
            <day>18</day>
            <volume>10</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">33919571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKenzie</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zaki</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Razvi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Drost</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Predictors of dyspnea in patients with advanced cancer.</article-title>
            <source>Ann Palliat Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-436</page-range>
            <pub-id pub-id-type="pmid">30180735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Currow</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness.</article-title>
            <source>Eur Respir J</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">32341113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wiggins</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Malignant mesothelioma.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2008</year>
            <month>Dec</month>
            <day>19</day>
            <volume>3</volume>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">19099560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reamy</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Odom</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Pleuritic Chest Pain: Sorting Through the Differential Diagnosis.</article-title>
            <source>Am Fam Physician</source>
            <year>2017</year>
            <month>Sep</month>
            <day>01</day>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>306</fpage>
            <page-range>306-312</page-range>
            <pub-id pub-id-type="pmid">28925655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiro</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Colice</surname>
                <given-names>GL</given-names>
              </name>
              <collab>American College of Chest Physicians</collab>
            </person-group>
            <article-title>Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition).</article-title>
            <source>Chest</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>132</volume>
            <issue>3 Suppl</issue>
            <fpage>149S</fpage>
            <page-range>149S-160S</page-range>
            <pub-id pub-id-type="pmid">17873166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Callemeyn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Haecke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Peetermans</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Blockmans</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance.</article-title>
            <source>Acta Clin Belg</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>123</fpage>
            <page-range>123-30</page-range>
            <pub-id pub-id-type="pmid">27104368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsuura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Schamroth sign.</article-title>
            <source>CMAJ</source>
            <year>2019</year>
            <month>Nov</month>
            <day>11</day>
            <volume>191</volume>
            <issue>45</issue>
            <fpage>E1251</fpage>
            <pub-id pub-id-type="pmid">31712360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vandemergel</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Renneboog</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, aetiologies and significance of clubbing in a department of general internal medicine.</article-title>
            <source>Eur J Intern Med</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>325</fpage>
            <page-range>325-9</page-range>
            <pub-id pub-id-type="pmid">18549933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spicknall</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Zirwas</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>English</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>1020</fpage>
            <page-range>1020-8</page-range>
            <pub-id pub-id-type="pmid">15928621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kesner</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dimachkie</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Barohn</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Lambert-Eaton Myasthenic Syndrome.</article-title>
            <source>Neurol Clin</source>
            <year>2018</year>
            <month>May</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>379</fpage>
            <page-range>379-394</page-range>
            <pub-id pub-id-type="pmid">29655456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pelosof</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic syndromes: an approach to diagnosis and treatment.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>85</volume>
            <issue>9</issue>
            <fpage>838</fpage>
            <page-range>838-54</page-range>
            <pub-id pub-id-type="pmid">20810794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burzyantseva</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dharmasena</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jayawardena</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rupanagudi</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hypercalcemia-leukocytosis syndrome in a patient with cavitating squamous cell carcinoma of the lung.</article-title>
            <source>Cases J</source>
            <year>2009</year>
            <month>Jan</month>
            <day>31</day>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>108</fpage>
            <pub-id pub-id-type="pmid">19183491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ectopic Cushing syndrome in small cell lung cancer: A case report and literature review.</article-title>
            <source>Thorac Cancer</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-117</page-range>
            <pub-id pub-id-type="pmid">28102935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zimmerman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Rapid Fire: Superior Vena Cava Syndrome.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-584</page-range>
            <pub-id pub-id-type="pmid">30037444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foroulis</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Darwiche</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Machairiotis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karapantzos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Superior sulcus (Pancoast) tumors: current evidence on diagnosis and radical treatment.</article-title>
            <source>J Thorac Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>5 Suppl 4</volume>
            <issue>Suppl 4</issue>
            <fpage>S342</fpage>
            <page-range>S342-58</page-range>
            <pub-id pub-id-type="pmid">24102007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Lav&#x000ed;n</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hypertrophic osteoarthropathy.</article-title>
            <source>Best Pract Res Clin Rheumatol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>101507</fpage>
            <pub-id pub-id-type="pmid">32291203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yap</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Skalski</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Schein</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Tomasian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masih</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matcuk</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Hypertrophic Osteoarthropathy: Clinical and Imaging Features.</article-title>
            <source>Radiographics</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>157</fpage>
            <page-range>157-195</page-range>
            <pub-id pub-id-type="pmid">27935768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leigh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Nurminen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Asbestos, Smoking and Lung Cancer: An Update.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2019</year>
            <month>Dec</month>
            <day>30</day>
            <volume>17</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31905913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roden</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Camus</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Iatrogenic pulmonary lesions.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>260</fpage>
            <page-range>260-271</page-range>
            <pub-id pub-id-type="pmid">29631763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsunoda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chihara</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients.</article-title>
            <source>Support Care Cancer</source>
            <year>1999</year>
            <month>May</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>128</fpage>
            <page-range>128-33</page-range>
            <pub-id pub-id-type="pmid">10335930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Pleural effusion.</article-title>
            <source>N Engl J Med</source>
            <year>2002</year>
            <month>Jun</month>
            <day>20</day>
            <volume>346</volume>
            <issue>25</issue>
            <fpage>1971</fpage>
            <page-range>1971-7</page-range>
            <pub-id pub-id-type="pmid">12075059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yernault</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bohadana</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Chest percussion.</article-title>
            <source>Eur Respir J</source>
            <year>1995</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>10</issue>
            <fpage>1756</fpage>
            <page-range>1756-60</page-range>
            <pub-id pub-id-type="pmid">8586135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keller</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>[Plessimeter Percussion].</article-title>
            <source>Pneumologie</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-39</page-range>
            <pub-id pub-id-type="pmid">30536248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Holroyd-Leduc</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Straus</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Does this patient have a pleural effusion?</article-title>
            <source>JAMA</source>
            <year>2009</year>
            <month>Jan</month>
            <day>21</day>
            <volume>301</volume>
            <issue>3</issue>
            <fpage>309</fpage>
            <page-range>309-17</page-range>
            <pub-id pub-id-type="pmid">19155458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karkhanis</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusion: diagnosis, treatment, and management.</article-title>
            <source>Open Access Emerg Med</source>
            <year>2012</year>
            <volume>4</volume>
            <fpage>31</fpage>
            <page-range>31-52</page-range>
            <pub-id pub-id-type="pmid">27147861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blackmore</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Dallas</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Crow</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Pleural fluid volume estimation: a chest radiograph prediction rule.</article-title>
            <source>Acad Radiol</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-9</page-range>
            <pub-id pub-id-type="pmid">8796649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodring</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Recognition of pleural effusion on supine radiographs: how much fluid is required?</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1984</year>
            <month>Jan</month>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-64</page-range>
            <pub-id pub-id-type="pmid">6606966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reuter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lindgaard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Laursen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Clementsen</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Bodtger</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Computed tomography of the chest in unilateral pleural effusions: outcome of the British Thoracic Society guideline.</article-title>
            <source>J Thorac Dis</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>1336</fpage>
            <page-range>1336-1346</page-range>
            <pub-id pub-id-type="pmid">31179075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khajotia</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Respiratory Clinics: MEDIASTINAL SHIFT: A SIGN OF SIGNIFICANT CLINICAL AND RADIOLOGICAL IMPORTANCE IN DIAGNOSIS OF MALIGNANT PLEURAL EFFUSION.</article-title>
            <source>Malays Fam Physician</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-6</page-range>
            <pub-id pub-id-type="pmid">25606244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Milross</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delaney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ntoumenopoulos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lung ultrasound has greater accuracy than conventional respiratory assessment tools for the diagnosis of pleural effusion, lung consolidation and collapse: a&#x000a0;systematic review.</article-title>
            <source>J Physiother</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-48</page-range>
            <pub-id pub-id-type="pmid">33353830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Havelock</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Teoh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Laws</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gleeson</surname>
                <given-names>F</given-names>
              </name>
              <collab>BTS Pleural Disease Guideline Group</collab>
            </person-group>
            <article-title>Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010.</article-title>
            <source>Thorax</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>65 Suppl 2</volume>
            <fpage>ii61</fpage>
            <page-range>ii61-76</page-range>
            <pub-id pub-id-type="pmid">20696688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Management of pleural effusion, empyema, and lung abscess.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-86</page-range>
            <pub-id pub-id-type="pmid">22379278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sureka</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thukral</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Radiological review of pleural tumors.</article-title>
            <source>Indian J Radiol Imaging</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>313</fpage>
            <page-range>313-20</page-range>
            <pub-id pub-id-type="pmid">24604935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Lung ultrasound in the critically ill.</article-title>
            <source>Ann Intensive Care</source>
            <year>2014</year>
            <month>Jan</month>
            <day>09</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">24401163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husain</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Hagopian</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wayman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Carmody</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Sonographic diagnosis of pneumothorax.</article-title>
            <source>J Emerg Trauma Shock</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <page-range>76-81</page-range>
            <pub-id pub-id-type="pmid">22416161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smargiassi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Inchingolo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zanforlin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soldati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Corbo</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Description of free-flowing pleural effusions in medical reports after echographic assessment.</article-title>
            <source>Respiration</source>
            <year>2013</year>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>439</fpage>
            <page-range>439-41</page-range>
            <pub-id pub-id-type="pmid">23548724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cantey</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Corbridge</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barsuk</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Complications of thoracentesis: incidence, risk factors, and strategies for prevention.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>378</fpage>
            <page-range>378-85</page-range>
            <pub-id pub-id-type="pmid">27093476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Purandare</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Rangarajan</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Imaging of lung cancer: Implications on staging and management.</article-title>
            <source>Indian J Radiol Imaging</source>
            <year>2015</year>
            <season>Apr-Jun</season>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-20</page-range>
            <pub-id pub-id-type="pmid">25969634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>CT in differential diagnosis of diffuse pleural disease.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>154</volume>
            <issue>3</issue>
            <fpage>487</fpage>
            <page-range>487-92</page-range>
            <pub-id pub-id-type="pmid">2106209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Pardina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bielsa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.</article-title>
            <source>Chest</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>147</volume>
            <issue>2</issue>
            <fpage>513</fpage>
            <page-range>513-519</page-range>
            <pub-id pub-id-type="pmid">25255186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Duan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>e0193714</fpage>
            <pub-id pub-id-type="pmid">29641601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amarante</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Younes</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Rigo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Sousa Cruz</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Interpretation of PET/CT findings in patients with advanced lung cancer who have undergone pleurodesis.</article-title>
            <source>Ecancermedicalscience</source>
            <year>2014</year>
            <volume>8</volume>
            <fpage>452</fpage>
            <pub-id pub-id-type="pmid">25183997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elboga</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Y&#x00131;lmaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Uyar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeki &#x000c7;elen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bak&#x00131;r</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dikensoy</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>The role of FDG PET-CT in differential diagnosis of pleural pathologies.</article-title>
            <source>Rev Esp Med Nucl Imagen Mol</source>
            <year>2012</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>187</fpage>
            <page-range>187-91</page-range>
            <pub-id pub-id-type="pmid">23067687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>XZ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>HZ</given-names>
              </name>
            </person-group>
            <article-title>Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>46</volume>
            <issue>7</issue>
            <fpage>1457</fpage>
            <page-range>1457-1467</page-range>
            <pub-id pub-id-type="pmid">30903197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cardinale</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ardissone</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gned</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sverzellati</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Piacibello</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Veltri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.</article-title>
            <source>Acta Biomed</source>
            <year>2017</year>
            <month>Aug</month>
            <day>23</day>
            <volume>88</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-142</page-range>
            <pub-id pub-id-type="pmid">28845826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaefer-Prokop</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Prokop</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>New imaging techniques in the treatment guidelines for lung cancer.</article-title>
            <source>Eur Respir J Suppl</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>35</volume>
            <fpage>71s</fpage>
            <page-range>71s-83s</page-range>
            <pub-id pub-id-type="pmid">12064683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Usuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Iwai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Funasaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sekimura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Motono</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matoba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Uramoto</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases.</article-title>
            <source>Cancers (Basel)</source>
            <year>2019</year>
            <month>Jun</month>
            <day>12</day>
            <volume>11</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">31212757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mercer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Corcoran</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Interpreting pleural fluid results&#x02002;.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2019</year>
            <month>May</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-217</page-range>
            <pub-id pub-id-type="pmid">31092513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khosla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rohatgi</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Paal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study.</article-title>
            <source>Lung India</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-37</page-range>
            <pub-id pub-id-type="pmid">28144058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renshaw</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Antman</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Cibas</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.</article-title>
            <source>Chest</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-9</page-range>
            <pub-id pub-id-type="pmid">8996002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nijhawan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rajwanshi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pleural fluid cytology samples in cases of suspected lung cancer: An experience from a tertiary care centre.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-201</page-range>
            <pub-id pub-id-type="pmid">28112486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>What is the clinical significance of transudative malignant pleural effusion?</article-title>
            <source>Korean J Intern Med</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>230</fpage>
            <page-range>230-3</page-range>
            <pub-id pub-id-type="pmid">14717231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arnold</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>De Fonseka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Medford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Investigating unilateral pleural effusions: the role of cytology.</article-title>
            <source>Eur Respir J</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">30262573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.</article-title>
            <source>Ann Transl Med</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>16</issue>
            <fpage>373</fpage>
            <pub-id pub-id-type="pmid">31555687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roth</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>O'Meara</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Cragun</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>The serum-effusion albumin gradient in the evaluation of pleural effusions.</article-title>
            <source>Chest</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>3</issue>
            <fpage>546</fpage>
            <page-range>546-9</page-range>
            <pub-id pub-id-type="pmid">2152757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasteh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Weidner</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Michael</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.</article-title>
            <source>Cancer Cytopathol</source>
            <year>2010</year>
            <month>Apr</month>
            <day>25</day>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-6</page-range>
            <pub-id pub-id-type="pmid">20209622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dixit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Gokhroo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Meena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management options in malignant pleural effusions.</article-title>
            <source>Lung India</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-166</page-range>
            <pub-id pub-id-type="pmid">28360465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qamar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rehman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mehdi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maheshwari</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Chauhan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Utility of Cytospin and Cell block Technology in Evaluation of Body Fluids and Urine Samples: A Comparative Study.</article-title>
            <source>J Cytol</source>
            <year>2018</year>
            <season>Apr-Jun</season>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-82</page-range>
            <pub-id pub-id-type="pmid">29643653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a Carretero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Manotas-Hidalgo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Romero Brugera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>El Bouayadi Mohamed</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusion of malignant aetiology: cell block technique to establish the diagnosis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <day>18</day>
            <volume>2016</volume>
            <pub-id pub-id-type="pmid">26994057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assawasaksakul</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Boonsarngsuk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Incharoen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>3161</fpage>
            <page-range>3161-3167</page-range>
            <pub-id pub-id-type="pmid">29221292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shidham</surname>
                <given-names>VB</given-names>
              </name>
            </person-group>
            <article-title>CellBlockistry: Chemistry and art of cell-block making - A detailed review of various historical options with recent advances.</article-title>
            <source>Cytojournal</source>
            <year>2019</year>
            <volume>16</volume>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">31367220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shivakumarswamy</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Arakeri</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Karigowdar</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Yelikar</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology.</article-title>
            <source>J Cytol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-5</page-range>
            <pub-id pub-id-type="pmid">22438610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shidham</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Layfield</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Cell-blocks and immunohistochemistry.</article-title>
            <source>Cytojournal</source>
            <year>2021</year>
            <volume>18</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">33598043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bairagya</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mandal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Closed pleural biopsy is still useful in the evaluation of malignant pleural effusion.</article-title>
            <source>J Lab Physicians</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-8</page-range>
            <pub-id pub-id-type="pmid">22923920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereyra</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>San-Jos&#x000e9;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferreiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Golpe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ant&#x000fa;nez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Barcala</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Abdulkader</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>&#x000c1;lvarez-Doba&#x000f1;o</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-N&#x000fa;&#x000f1;ez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Role of blind closed pleural biopsy in the managment of pleural exudates.</article-title>
            <source>Can Respir J</source>
            <year>2013</year>
            <season>Sep-Oct</season>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>362</fpage>
            <page-range>362-6</page-range>
            <pub-id pub-id-type="pmid">23951560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koegelenberg</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Diacon</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Pleural controversy: close needle pleural biopsy or thoracoscopy-which first?</article-title>
            <source>Respirology</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>738</fpage>
            <page-range>738-46</page-range>
            <pub-id pub-id-type="pmid">21435098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant pleural effusion.</article-title>
            <source>Ann Intern Med</source>
            <year>1997</year>
            <month>May</month>
            <day>15</day>
            <volume>126</volume>
            <issue>10</issue>
            <fpage>768</fpage>
            <page-range>768-74</page-range>
            <pub-id pub-id-type="pmid">9148649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>CWC</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>DKY</given-names>
              </name>
              <name>
                <surname>See</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Safety of Thoracentesis and Tube Thoracostomy in Patients With Uncorrected Coagulopathy: A Systematic Review and Meta-analysis.</article-title>
            <source>Chest</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>160</volume>
            <issue>5</issue>
            <fpage>1875</fpage>
            <page-range>1875-1889</page-range>
            <pub-id pub-id-type="pmid">33905681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goligher</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Leis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Adhikari</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Utility and safety of draining pleural effusions in mechanically ventilated patients: a systematic review and meta-analysis.</article-title>
            <source>Crit Care</source>
            <year>2011</year>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>R46</fpage>
            <pub-id pub-id-type="pmid">21288334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheta</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Procedural sedation analgesia.</article-title>
            <source>Saudi J Anaesth</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-6</page-range>
            <pub-id pub-id-type="pmid">20668560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ault</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Scher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feinglass</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barsuk</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Thoracentesis outcomes: a 12-year experience.</article-title>
            <source>Thorax</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>70</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-32</page-range>
            <pub-id pub-id-type="pmid">25378543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manian</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>The role of postoperative factors in surgical site infections: time to take notice.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Nov</month>
            <day>01</day>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>1272</fpage>
            <page-range>1272-6</page-range>
            <pub-id pub-id-type="pmid">25028464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwiatt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tarbox</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seamon</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Swaroop</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cipolla</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hallenbeck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davido</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Lindsey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Doraiswamy</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Galwankar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tulman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Latchana</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Papadimos</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Stawicki</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Thoracostomy tubes: A comprehensive review of complications and related topics.</article-title>
            <source>Int J Crit Illn Inj Sci</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-55</page-range>
            <pub-id pub-id-type="pmid">25024942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Samaha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>El Bitar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Esper</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Maroun</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Intercostal Artery Laceration: Rare Complication of Thoracentesis and Role of Ultrasound in Early Detection.</article-title>
            <source>Case Rep Pulmonol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>6491083</fpage>
            <pub-id pub-id-type="pmid">28831322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yacovone</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Kartan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bautista</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intercostal artery laceration following thoracentesis.</article-title>
            <source>Respir Care</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>11</issue>
            <fpage>1495</fpage>
            <page-range>1495-8</page-range>
            <pub-id pub-id-type="pmid">20979678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salamonsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Steinke</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fielding</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Thoracic ultrasound demonstrates variable location of the intercostal artery.</article-title>
            <source>Respiration</source>
            <year>2012</year>
            <volume>83</volume>
            <issue>4</issue>
            <fpage>323</fpage>
            <page-range>323-9</page-range>
            <pub-id pub-id-type="pmid">22301442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalifatidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lazaridis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mpoukovinas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Karavasilis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kioumis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pitsiou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papaiwannou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karavergou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sarika</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kapanidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakkas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Korantzis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lampaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Thoracocentesis: from bench to bed.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>Suppl 1</issue>
            <fpage>S1</fpage>
            <page-range>S1-4</page-range>
            <pub-id pub-id-type="pmid">25774301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sachdeva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shepherd</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Thoracentesis and thoracic ultrasound: state of the art in 2013.</article-title>
            <source>Clin Chest Med</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">23411051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r142">
          <label>142</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krausz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manny</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A safe method of thoracentesis.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>1976</year>
            <month>Aug</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>323</fpage>
            <page-range>323-5</page-range>
            <pub-id pub-id-type="pmid">957750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r143">
          <label>143</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jany</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2019</year>
            <month>May</month>
            <day>24</day>
            <volume>116</volume>
            <issue>21</issue>
            <fpage>377</fpage>
            <page-range>377-386</page-range>
            <pub-id pub-id-type="pmid">31315808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r144">
          <label>144</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacDuff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>J</given-names>
              </name>
              <collab>BTS Pleural Disease Guideline Group</collab>
            </person-group>
            <article-title>Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010.</article-title>
            <source>Thorax</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>65 Suppl 2</volume>
            <fpage>ii18</fpage>
            <page-range>ii18-31</page-range>
            <pub-id pub-id-type="pmid">20696690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r145">
          <label>145</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lentz</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Shojaee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grosu</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Rickman</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Roller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pannu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>DePew</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Debiane</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Cicenia</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Akulian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Walston</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Jagan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Yarmus</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Feller-Kopman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Maldonado</surname>
                <given-names>F</given-names>
              </name>
              <collab>Interventional Pulmonary Outcomes Group</collab>
            </person-group>
            <article-title>The Impact of Gravity vs&#x000a0;Suction-driven Therapeutic Thoracentesis on Pressure-related Complications: The GRAVITAS Multicenter Randomized Controlled Trial.</article-title>
            <source>Chest</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>157</volume>
            <issue>3</issue>
            <fpage>702</fpage>
            <page-range>702-711</page-range>
            <pub-id pub-id-type="pmid">31711990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r146">
          <label>146</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feller-Kopman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Berkowitz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boiselle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Large-volume thoracentesis and the risk of reexpansion pulmonary edema.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>1656</fpage>
            <page-range>1656-61</page-range>
            <pub-id pub-id-type="pmid">17954079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r147">
          <label>147</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giannou</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Stathopoulos</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Switching off malignant pleural effusion formation-fantasy or future?</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>1009</fpage>
            <page-range>1009-20</page-range>
            <pub-id pub-id-type="pmid">26150914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r148">
          <label>148</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lentz</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lerner</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Pannu</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Merrick</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Roller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Walston</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Valenti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goddard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Rickman</surname>
                <given-names>OB</given-names>
              </name>
              <name>
                <surname>Yarmus</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Maldonado</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Routine monitoring with pleural manometry during therapeutic large-volume thoracentesis to prevent pleural-pressure-related complications: a multicentre, single-blind randomised controlled trial.</article-title>
            <source>Lancet Respir Med</source>
            <year>2019</year>
            <month>May</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>447</fpage>
            <page-range>447-455</page-range>
            <pub-id pub-id-type="pmid">30772283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r149">
          <label>149</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mytinger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gershman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shojaee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2020</year>
            <month>Aug</month>
            <day>01</day>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>448</fpage>
            <page-range>448-450</page-range>
            <pub-id pub-id-type="pmid">32421351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r150">
          <label>150</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sunderland</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Maweni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Akunuri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karnovitch</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Re-expansion pulmonary oedema: a novel emergency therapeutic option.</article-title>
            <source>BMJ Case Rep</source>
            <year>2016</year>
            <month>Apr</month>
            <day>27</day>
            <volume>2016</volume>
            <pub-id pub-id-type="pmid">27122103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r151">
          <label>151</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verhagen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Buijtenen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Geeraedts</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Reexpansion pulmonary edema after chest drainage for pneumothorax: A case report and literature overview.</article-title>
            <source>Respir Med Case Rep</source>
            <year>2015</year>
            <volume>14</volume>
            <fpage>10</fpage>
            <page-range>10-2</page-range>
            <pub-id pub-id-type="pmid">26029567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r152">
          <label>152</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corcoran</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wrightson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hallifax</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Pleural procedural complications: prevention and management.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>1058</fpage>
            <page-range>1058-67</page-range>
            <pub-id pub-id-type="pmid">26150919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r153">
          <label>153</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasmani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Irani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Okoli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Re-expansion pulmonary edema following thoracentesis.</article-title>
            <source>CMAJ</source>
            <year>2010</year>
            <month>Dec</month>
            <day>14</day>
            <volume>182</volume>
            <issue>18</issue>
            <fpage>2000</fpage>
            <page-range>2000-2</page-range>
            <pub-id pub-id-type="pmid">20643838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r154">
          <label>154</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Austin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al-Faris</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Modi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chopra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A transudative chylothorax associated with superior vena cava syndrome.</article-title>
            <source>Respir Med Case Rep</source>
            <year>2019</year>
            <volume>28</volume>
            <fpage>100898</fpage>
            <pub-id pub-id-type="pmid">31338288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r155">
          <label>155</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahajan</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Reexpansion pulmonary edema.</article-title>
            <source>Chest</source>
            <year>1979</year>
            <month>Feb</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>192</fpage>
            <page-range>192-4</page-range>
            <pub-id pub-id-type="pmid">421556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r156">
          <label>156</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mokotedi</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Balik</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Is the mechanism of re-expansion pulmonary oedema in a heart-lung interaction?</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Jul</month>
            <day>18</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">28720600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r157">
          <label>157</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodrigues</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Romaneli</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Fraga</surname>
                <given-names>Ade M</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Tresoldi</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Reexpansion pulmonary edema in children.</article-title>
            <source>Rev Paul Pediatr</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>411</fpage>
            <page-range>411-5</page-range>
            <pub-id pub-id-type="pmid">24142327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r158">
          <label>158</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Volpicelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fogliati</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Radeschi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frascisco</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A case of unilateral re-expansion pulmonary oedema successfully treated with non-invasive continuous positive airway pressure.</article-title>
            <source>Eur J Emerg Med</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>291</fpage>
            <page-range>291-4</page-range>
            <pub-id pub-id-type="pmid">15359205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r159">
          <label>159</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janocik</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Killeen</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Re-expansion pulmonary edema: a preventable complication.</article-title>
            <source>J Ky Med Assoc</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>143</fpage>
            <page-range>143-8</page-range>
            <pub-id pub-id-type="pmid">8320499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r160">
          <label>160</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarver</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Conces</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Reexpansion pulmonary edema.</article-title>
            <source>J Thorac Imaging</source>
            <year>1996</year>
            <season>Summer</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>198</fpage>
            <page-range>198-209</page-range>
            <pub-id pub-id-type="pmid">8784733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r161">
          <label>161</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kowarik</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bechtold</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Reexpansion pulmonary edema following a posttraumatic pneumothorax: a case report and review of the literature.</article-title>
            <source>World J Emerg Surg</source>
            <year>2011</year>
            <month>Sep</month>
            <day>02</day>
            <volume>6</volume>
            <fpage>32</fpage>
            <pub-id pub-id-type="pmid">21888638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r162">
          <label>162</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morioka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kojima</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Iwata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okachi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Re-expansion pulmonary edema: evaluation of risk factors in 173 episodes of spontaneous pneumothorax.</article-title>
            <source>Respir Investig</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-9</page-range>
            <pub-id pub-id-type="pmid">23561257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r163">
          <label>163</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lam</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Life threatening re-expansion hypotension and pulmonary oedema following treatment of a pneumothorax.</article-title>
            <source>Singapore Med J</source>
            <year>1989</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>502</fpage>
            <page-range>502-5</page-range>
            <pub-id pub-id-type="pmid">2617307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r164">
          <label>164</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gleeson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thiessen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Reexpansion pulmonary edema: computed tomography findings in 22 patients.</article-title>
            <source>J Thorac Imaging</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-41</page-range>
            <pub-id pub-id-type="pmid">20489660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r165">
          <label>165</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kepka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lemaitre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Marx</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bilbault</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Desmettre</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A common gesture with a rare but potentially severe complication: Re-expansion pulmonary edema following chest tube drainage.</article-title>
            <source>Respir Med Case Rep</source>
            <year>2019</year>
            <volume>27</volume>
            <fpage>100838</fpage>
            <pub-id pub-id-type="pmid">31016133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r166">
          <label>166</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komatsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tomii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ishihara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Unilateral re-expansion pulmonary edema following treatment of pneumothorax with exceptionally massive sputum production, followed by circulatory collapse.</article-title>
            <source>Can Respir J</source>
            <year>2010</year>
            <season>Mar-Apr</season>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-5</page-range>
            <pub-id pub-id-type="pmid">20422058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r167">
          <label>167</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Contralateral reexpansion pulmonary edema with ipsilateral collapsed lung after pleural effusion drainage: a case report.</article-title>
            <source>J Cardiothorac Surg</source>
            <year>2015</year>
            <month>May</month>
            <day>08</day>
            <volume>10</volume>
            <fpage>68</fpage>
            <pub-id pub-id-type="pmid">25952365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r168">
          <label>168</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mierzejewski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Korczynski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krenke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Janssen</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration.</article-title>
            <source>Respir Res</source>
            <year>2019</year>
            <month>Nov</month>
            <day>07</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>247</fpage>
            <pub-id pub-id-type="pmid">31699094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r169">
          <label>169</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Dokhan</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>El-Sessy</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Eltaweel</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.</article-title>
            <source>J Cardiothorac Surg</source>
            <year>2015</year>
            <month>May</month>
            <day>01</day>
            <volume>10</volume>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">25947235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r170">
          <label>170</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;zkul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Turna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Demirkaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aksoy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaynak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial.</article-title>
            <source>J Thorac Dis</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>12</issue>
            <fpage>1731</fpage>
            <page-range>1731-5</page-range>
            <pub-id pub-id-type="pmid">25589966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r171">
          <label>171</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zamboni</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Baretta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cunha</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Cardoso</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Important prognostic factors for survival in patients with malignant pleural effusion.</article-title>
            <source>BMC Pulm Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>28</day>
            <volume>15</volume>
            <fpage>29</fpage>
            <pub-id pub-id-type="pmid">25887349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r172">
          <label>172</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hallifax</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Chest Drain Size: the Debate Continues.</article-title>
            <source>Curr Pulmonol Rep</source>
            <year>2017</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-29</page-range>
            <pub-id pub-id-type="pmid">28344925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r173">
          <label>173</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lardinois</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vogt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hegyi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Baslam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weder</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Non-steroidal anti-inflammatory drugs decrease the quality of pleurodesis after mechanical pleural abrasion.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2004</year>
            <month>May</month>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>865</fpage>
            <page-range>865-71</page-range>
            <pub-id pub-id-type="pmid">15082296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r174">
          <label>174</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer.</article-title>
            <source>Int J Clin Exp Med</source>
            <year>2015</year>
            <volume>8</volume>
            <issue>10</issue>
            <fpage>18945</fpage>
            <page-range>18945-53</page-range>
            <pub-id pub-id-type="pmid">26770519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r175">
          <label>175</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Debeljak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kecelj</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Triller</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Letonja</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kern</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Debevec</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rozman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.</article-title>
            <source>J BUON</source>
            <year>2006</year>
            <season>Oct-Dec</season>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-7</page-range>
            <pub-id pub-id-type="pmid">17309178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r176">
          <label>176</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terra</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Bibas</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Pego-Fernandes</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Jatene</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status.</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2011</year>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-6</page-range>
            <pub-id pub-id-type="pmid">21484035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r177">
          <label>177</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olivares-Torres</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Laniado-Labor&#x000ed;n</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ch&#x000e1;vez-Garc&#x000ed;a</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Le&#x000f3;n-Gastelum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reyes-Escamilla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Iodopovidone pleurodesis for recurrent pleural effusions.</article-title>
            <source>Chest</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>581</fpage>
            <page-range>581-3</page-range>
            <pub-id pub-id-type="pmid">12171835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r178">
          <label>178</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neto</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>de Oliveira</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Vianna</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Terra</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.</article-title>
            <source>Respirology</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-8</page-range>
            <pub-id pub-id-type="pmid">19947987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r179">
          <label>179</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacEachern</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tremblay</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pleural controversy: pleurodesis versus indwelling pleural catheters for malignant effusions.</article-title>
            <source>Respirology</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>747</fpage>
            <page-range>747-54</page-range>
            <pub-id pub-id-type="pmid">21545373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r180">
          <label>180</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Laskawiec-Szkonter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piotrowska</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial.</article-title>
            <source>BMJ Open</source>
            <year>2014</year>
            <month>Nov</month>
            <day>26</day>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>e007045</fpage>
            <pub-id pub-id-type="pmid">25428632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r181">
          <label>181</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halford</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Clive</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Is there a role for prophylactic radiotherapy to intervention tract sites in patients with malignant pleural mesothelioma?</article-title>
            <source>Transl Lung Cancer Res</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>584</fpage>
            <page-range>584-592</page-range>
            <pub-id pub-id-type="pmid">30450297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r182">
          <label>182</label>
          <element-citation publication-type="journal">
            <collab>American Thoracic Society</collab>
            <article-title>Management of malignant pleural effusions.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>162</volume>
            <issue>5</issue>
            <fpage>1987</fpage>
            <page-range>1987-2001</page-range>
            <pub-id pub-id-type="pmid">11069845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r183">
          <label>183</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brant</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eaton</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Serious complications with talc slurry pleurodesis.</article-title>
            <source>Respirology</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-5</page-range>
            <pub-id pub-id-type="pmid">11555375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r184">
          <label>184</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weissberg</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Talc pleurodesis: a matter of priority.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>169</volume>
            <issue>3</issue>
            <fpage>911</fpage>
            <pub-id pub-id-type="pmid">9275925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r185">
          <label>185</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dresler</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Olak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herndon</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Scalzetti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fleishman</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kernstine</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Demmy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jablons</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kohman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Haasler</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>DJ</given-names>
              </name>
              <collab>Cooperative Groups Cancer and Leukemia Group B</collab>
              <collab>Eastern Cooperative Oncology Group</collab>
              <collab>North Central Cooperative Oncology Group</collab>
              <collab>Radiation Therapy Oncology Group</collab>
            </person-group>
            <article-title>Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>909</fpage>
            <page-range>909-15</page-range>
            <pub-id pub-id-type="pmid">15764775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r186">
          <label>186</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yim</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>62</volume>
            <issue>6</issue>
            <fpage>1655</fpage>
            <page-range>1655-8</page-range>
            <pub-id pub-id-type="pmid">8957368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r187">
          <label>187</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antony</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Nasreen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mohammed</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Sriram</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Loddenkemper</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis.</article-title>
            <source>Chest</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>126</volume>
            <issue>5</issue>
            <fpage>1522</fpage>
            <page-range>1522-8</page-range>
            <pub-id pub-id-type="pmid">15539722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r188">
          <label>188</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shojaee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Thoracoscopy: medical versus surgical-in the management of pleural diseases.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>Suppl 4</issue>
            <fpage>S339</fpage>
            <page-range>S339-51</page-range>
            <pub-id pub-id-type="pmid">26807282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r189">
          <label>189</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steger</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mika</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Toomes</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kyriss</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ziemer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Friedel</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>83</volume>
            <issue>6</issue>
            <fpage>1940</fpage>
            <page-range>1940-5</page-range>
            <pub-id pub-id-type="pmid">17532375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r190">
          <label>190</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van de Pas</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>van Roozendaal</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Wanders</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Custers</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Vissers</surname>
                <given-names>YLJ</given-names>
              </name>
              <name>
                <surname>de Loos</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Bronchopleural Fistula After Concurrent Chemoradiotherapy.</article-title>
            <source>Adv Radiat Oncol</source>
            <year>2020</year>
            <season>May-Jun</season>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>511</fpage>
            <page-range>511-515</page-range>
            <pub-id pub-id-type="pmid">32529148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r191">
          <label>191</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Piotrowska</surname>
                <given-names>HEG</given-names>
              </name>
              <name>
                <surname>Laskawiec-Szkonter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Luengo-Fernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pepperell</surname>
                <given-names>JCT</given-names>
              </name>
              <name>
                <surname>Evison</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Holme</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Al-Aloul</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Blyth</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Downer</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Herre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sivasothy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Menzies</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Munavvar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kyi</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Prudon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hettiarachchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chakrabarti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kavidasan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Zahan-Evans</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Quaddy</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Edey</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Clive</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>MHR</given-names>
              </name>
              <name>
                <surname>Mei</surname>
                <given-names>XW</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Slade</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sivier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2020</year>
            <month>Jan</month>
            <day>07</day>
            <volume>323</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-69</page-range>
            <pub-id pub-id-type="pmid">31804680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r192">
          <label>192</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Luengo-Fernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.</article-title>
            <source>Health Technol Assess</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>26</issue>
            <fpage>1</fpage>
            <page-range>1-90</page-range>
            <pub-id pub-id-type="pmid">32525474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r193">
          <label>193</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chalhoub</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saqib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Castellano</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Indwelling pleural catheters: complications and management strategies.</article-title>
            <source>J Thorac Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>4659</fpage>
            <page-range>4659-4666</page-range>
            <pub-id pub-id-type="pmid">30174919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r194">
          <label>194</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lui</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Complications of indwelling pleural catheter use and their management.</article-title>
            <source>BMJ Open Respir Res</source>
            <year>2016</year>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>e000123</fpage>
            <pub-id pub-id-type="pmid">26870384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r195">
          <label>195</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000fc;cke</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Steffen</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Riedel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Efficacy and Safety of Indwelling Pleural Catheters].</article-title>
            <source>Zentralbl Chir</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>3</issue>
            <fpage>290</fpage>
            <page-range>290-295</page-range>
            <pub-id pub-id-type="pmid">29325199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r196">
          <label>196</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertolaccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Terzi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of malignant pleural effusions in patients with trapped lung with indwelling pleural catheter: how to do it.</article-title>
            <source>J Vis Surg</source>
            <year>2016</year>
            <volume>2</volume>
            <fpage>44</fpage>
            <pub-id pub-id-type="pmid">29078472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r197">
          <label>197</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fysh</surname>
                <given-names>ETH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>BCH</given-names>
              </name>
              <name>
                <surname>Yap</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Horwood</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Piccolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>DCL</given-names>
              </name>
              <name>
                <surname>Garske</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Shrestha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kosky</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Read</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YCG</given-names>
              </name>
            </person-group>
            <article-title>Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Nov</month>
            <day>21</day>
            <volume>318</volume>
            <issue>19</issue>
            <fpage>1903</fpage>
            <page-range>1903-1912</page-range>
            <pub-id pub-id-type="pmid">29164255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r198">
          <label>198</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivakumar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saigal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Quality of life after interventions for malignant pleural effusions: a systematic review.</article-title>
            <source>BMJ Support Palliat Care</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-54</page-range>
            <pub-id pub-id-type="pmid">31243020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r199">
          <label>199</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olfert</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Penz</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Manns</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Luengo-Fernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.</article-title>
            <source>Respirology</source>
            <year>2017</year>
            <month>May</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>764</fpage>
            <page-range>764-770</page-range>
            <pub-id pub-id-type="pmid">27983774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r200">
          <label>200</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zahan-Evans</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Edey</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Stadon</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Tremblay</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>A Novel Drug-Eluting Indwelling Pleural Catheter for the Management of Malignant Effusions.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2018</year>
            <month>Jan</month>
            <day>01</day>
            <volume>197</volume>
            <issue>1</issue>
            <fpage>136</fpage>
            <page-range>136-138</page-range>
            <pub-id pub-id-type="pmid">28574275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r201">
          <label>201</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dipper</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Preston</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Clive</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Interventions for the management of malignant pleural effusions: a network meta-analysis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2020</year>
            <month>Apr</month>
            <day>21</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>CD010529</fpage>
            <pub-id pub-id-type="pmid">32315458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r202">
          <label>202</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batra</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Antony</surname>
                <given-names>VB</given-names>
              </name>
            </person-group>
            <article-title>Pleural mesothelial cells in pleural and lung diseases.</article-title>
            <source>J Thorac Dis</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>964</fpage>
            <page-range>964-80</page-range>
            <pub-id pub-id-type="pmid">26150910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r203">
          <label>203</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Doelken</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>The unexpandable lung.</article-title>
            <source>F1000 Med Rep</source>
            <year>2010</year>
            <month>Oct</month>
            <day>21</day>
            <volume>2</volume>
            <fpage>77</fpage>
            <pub-id pub-id-type="pmid">21173837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r204">
          <label>204</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hallifax</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Talwar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wrightson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Edey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gleeson</surname>
                <given-names>FV</given-names>
              </name>
            </person-group>
            <article-title>State-of-the-art: Radiological investigation of pleural disease.</article-title>
            <source>Respir Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>124</volume>
            <fpage>88</fpage>
            <page-range>88-99</page-range>
            <pub-id pub-id-type="pmid">28233652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r205">
          <label>205</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Maldonado</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chopra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Unexpandable lung from pleural disease.</article-title>
            <source>Respirology</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>160</fpage>
            <page-range>160-167</page-range>
            <pub-id pub-id-type="pmid">29064169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r206">
          <label>206</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertolaccini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paiano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pomari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Assante</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Terzi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Indwelling Pleural Catheters: A Clinical Option in Trapped Lung.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-55</page-range>
            <pub-id pub-id-type="pmid">27865327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r207">
          <label>207</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masoud</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>El-Zorkany</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Assal</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion.</article-title>
            <source>Tuberc Respir Dis (Seoul)</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-73</page-range>
            <pub-id pub-id-type="pmid">33161689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r208">
          <label>208</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>Pneumothorax.</article-title>
            <source>Tuberc Respir Dis (Seoul)</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>76</volume>
            <issue>3</issue>
            <fpage>99</fpage>
            <page-range>99-104</page-range>
            <pub-id pub-id-type="pmid">24734096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r209">
          <label>209</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dugan</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Laxmanan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Murgu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hogarth</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Management of Persistent Air Leaks.</article-title>
            <source>Chest</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>152</volume>
            <issue>2</issue>
            <fpage>417</fpage>
            <page-range>417-423</page-range>
            <pub-id pub-id-type="pmid">28267436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r210">
          <label>210</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lazarus</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Casal</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Persistent air leaks: a review with an emphasis on bronchoscopic management.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>4660</fpage>
            <page-range>4660-4670</page-range>
            <pub-id pub-id-type="pmid">29268535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r211">
          <label>211</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lois</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Noppen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bronchopleural fistulas: an overview of the problem with special focus on endoscopic management.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>128</volume>
            <issue>6</issue>
            <fpage>3955</fpage>
            <page-range>3955-65</page-range>
            <pub-id pub-id-type="pmid">16354867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r212">
          <label>212</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keshishyan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Revelo</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Epelbaum</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Bronchoscopic management of prolonged air leak.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>Suppl 10</issue>
            <fpage>S1034</fpage>
            <page-range>S1034-S1046</page-range>
            <pub-id pub-id-type="pmid">29214063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r213">
          <label>213</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bielsa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-Juan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Panadero</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic and prognostic implications of pleural adhesions in malignant effusions.</article-title>
            <source>J Thorac Oncol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>11</issue>
            <fpage>1251</fpage>
            <page-range>1251-6</page-range>
            <pub-id pub-id-type="pmid">18978559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r214">
          <label>214</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Panadero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Janssen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Astoul</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion.</article-title>
            <source>Eur Respir J</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>409</fpage>
            <page-range>409-22</page-range>
            <pub-id pub-id-type="pmid">16880371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r215">
          <label>215</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Clive</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Stanton</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Al-Aloul</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hart-Thomas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pepperell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Evison</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Guhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Callister</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Sathyamurthy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rehal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Corcoran</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hallifax</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dobson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wrightson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YCG</given-names>
              </name>
              <name>
                <surname>Nunn</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2018</year>
            <month>Feb</month>
            <day>15</day>
            <volume>197</volume>
            <issue>4</issue>
            <fpage>502</fpage>
            <page-range>502-508</page-range>
            <pub-id pub-id-type="pmid">28926296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r216">
          <label>216</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soni</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Velez</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Schnobrich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dancel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Mayo</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound in the diagnosis and management of pleural effusions.</article-title>
            <source>J Hosp Med</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>811</fpage>
            <page-range>811-6</page-range>
            <pub-id pub-id-type="pmid">26218493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r217">
          <label>217</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altmann</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Crossingham</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Oct</month>
            <day>30</day>
            <volume>2019</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">31684683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r218">
          <label>218</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okur</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baysungur</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tezel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ergene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Okur</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Halezeroglu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Streptokinase for malignant pleural effusions: a randomized controlled study.</article-title>
            <source>Asian Cardiovasc Thorac Ann</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>3-4</issue>
            <fpage>238</fpage>
            <page-range>238-43</page-range>
            <pub-id pub-id-type="pmid">21885549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r219">
          <label>219</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krenke</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nasilowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Korczynski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gorska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Przybylowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chazan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Incidence and aetiology of eosinophilic pleural effusion.</article-title>
            <source>Eur Respir J</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>1111</fpage>
            <page-range>1111-7</page-range>
            <pub-id pub-id-type="pmid">19386682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r220">
          <label>220</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>A narrative review of malignant eosinophilic pleural effusion: incidence, etiology and prognostic significance.</article-title>
            <source>Ann Palliat Med</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>2314</fpage>
            <page-range>2314-2322</page-range>
            <pub-id pub-id-type="pmid">33549025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r221">
          <label>221</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeuchi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Okano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Machida</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Atagi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kondou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kadota</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hatakeyama</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Naruse</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shinohara</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.</article-title>
            <source>Cancer Immunol Immunother</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>365</fpage>
            <page-range>365-372</page-range>
            <pub-id pub-id-type="pmid">34170380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r222">
          <label>222</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lending</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>El Ghani</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Kaykov</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Svirsky</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Altman</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis.</article-title>
            <source>Indian J Surg Oncol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-60</page-range>
            <pub-id pub-id-type="pmid">33814832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r223">
          <label>223</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parshall</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Schwartzstein</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Banzett</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Bourbeau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Calverley</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gift</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Harver</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lareau</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Mahler</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Meek</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>DE</given-names>
              </name>
              <collab>American Thoracic Society Committee on Dyspnea</collab>
            </person-group>
            <article-title>An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2012</year>
            <month>Feb</month>
            <day>15</day>
            <volume>185</volume>
            <issue>4</issue>
            <fpage>435</fpage>
            <page-range>435-52</page-range>
            <pub-id pub-id-type="pmid">22336677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r224">
          <label>224</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ambrosino</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Serradori</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Determining the cause of dyspnoea: linguistic and biological descriptors.</article-title>
            <source>Chron Respir Dis</source>
            <year>2006</year>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>117</fpage>
            <page-range>117-22</page-range>
            <pub-id pub-id-type="pmid">16916005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r225">
          <label>225</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bland</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Oxberry</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Abernethy</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Currow</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Opioids for chronic refractory breathlessness: patient predictors of beneficial response.</article-title>
            <source>Eur Respir J</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>758</fpage>
            <page-range>758-66</page-range>
            <pub-id pub-id-type="pmid">23258776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r226">
          <label>226</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hui</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maddocks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ekstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Ogliari</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ripamonti</surname>
                <given-names>C</given-names>
              </name>
              <collab>ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org</collab>
            </person-group>
            <article-title>Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines<sup>&#x02020;</sup>.</article-title>
            <source>ESMO Open</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>e001038</fpage>
            <pub-id pub-id-type="pmid">33303485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r227">
          <label>227</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Yorke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hansen-Flaschen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lansing</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ekstr&#x000f6;m</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Similowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Currow</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness.</article-title>
            <source>Eur Respir J</source>
            <year>2017</year>
            <month>May</month>
            <volume>49</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">28546269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r228">
          <label>228</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishino</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Dyspnoea: underlying mechanisms and treatment.</article-title>
            <source>Br J Anaesth</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>106</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-74</page-range>
            <pub-id pub-id-type="pmid">21378105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r229">
          <label>229</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>West</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Popkess-Vawter</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The subjective and psychosocial nature of breathlessness.</article-title>
            <source>J Adv Nurs</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>622</fpage>
            <page-range>622-6</page-range>
            <pub-id pub-id-type="pmid">7822595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r230">
          <label>230</label>
          <element-citation publication-type="journal">
            <article-title>Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>1999</year>
            <month>Jan</month>
            <volume>159</volume>
            <issue>1</issue>
            <fpage>321</fpage>
            <page-range>321-40</page-range>
            <pub-id pub-id-type="pmid">9872857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r231">
          <label>231</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laviolette</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Laveneziana</surname>
                <given-names>P</given-names>
              </name>
              <collab>ERS Research Seminar Faculty</collab>
            </person-group>
            <article-title>Dyspnoea: a multidimensional and multidisciplinary approach.</article-title>
            <source>Eur Respir J</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>1750</fpage>
            <page-range>1750-62</page-range>
            <pub-id pub-id-type="pmid">24525437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r232">
          <label>232</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deshpande</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Rajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sudeepthi</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Abdul Nazir</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Patient-reported outcomes: A new era in clinical research.</article-title>
            <source>Perspect Clin Res</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>137</fpage>
            <page-range>137-44</page-range>
            <pub-id pub-id-type="pmid">22145124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r233">
          <label>233</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dorman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.</article-title>
            <source>Palliat Med</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-91</page-range>
            <pub-id pub-id-type="pmid">17363394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r234">
          <label>234</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muller</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gon&#x000e7;alves</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Fontoura</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Mattiello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Florian</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Applicability of the London Chest Activity of Daily Living scale in patients on the waiting list for lung transplantation.</article-title>
            <source>J Bras Pneumol</source>
            <year>2013</year>
            <season>Jan-Feb</season>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>92</fpage>
            <page-range>92-7</page-range>
            <pub-id pub-id-type="pmid">23503491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r235">
          <label>235</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simon</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Bausewein</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schildmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Higginson</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Magnussen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scheve</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ramsenthaler</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Episodic breathlessness in patients with advanced disease: a systematic review.</article-title>
            <source>J Pain Symptom Manage</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>561</fpage>
            <page-range>561-78</page-range>
            <pub-id pub-id-type="pmid">22921180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r236">
          <label>236</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Booth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wade</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Oxygen or air for palliation of breathlessness in advanced cancer.</article-title>
            <source>J R Soc Med</source>
            <year>2003</year>
            <month>May</month>
            <volume>96</volume>
            <issue>5</issue>
            <fpage>215</fpage>
            <page-range>215-8</page-range>
            <pub-id pub-id-type="pmid">12724429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r237">
          <label>237</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simon</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Higginson</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harding</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weing&#x000e4;rtner</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bausewein</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Oct</month>
            <day>20</day>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>CD007354</fpage>
            <pub-id pub-id-type="pmid">27764523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r238">
          <label>238</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haywood</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duc</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Good</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rickett</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vayne-Bossert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Feb</month>
            <day>20</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>CD012704</fpage>
            <pub-id pub-id-type="pmid">30784058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r239">
          <label>239</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prado</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>DBD</given-names>
              </name>
              <name>
                <surname>Us&#x000f3;n J&#x000fa;nior</surname>
                <given-names>PLS</given-names>
              </name>
              <name>
                <surname>Taranto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fran&#x000e7;a</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Eiger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mariano</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Del Giglio</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.</article-title>
            <source>BMC Palliat Care</source>
            <year>2018</year>
            <month>Jan</month>
            <day>04</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">29301574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r240">
          <label>240</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Breen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Palliative Sedation, Compassionate Extubation, and the Principle of Double Effect: An Ethical Analysis.</article-title>
            <source>Am J Hosp Palliat Care</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>12</issue>
            <fpage>1536</fpage>
            <page-range>1536-1540</page-range>
            <pub-id pub-id-type="pmid">33657860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r241">
          <label>241</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shaffer</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Nipp</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El-Jawahri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pirl</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Temel</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Distress is Interdependent in Patients and Caregivers with Newly Diagnosed Incurable Cancers.</article-title>
            <source>Ann Behav Med</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>519</fpage>
            <page-range>519-531</page-range>
            <pub-id pub-id-type="pmid">28097515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r242">
          <label>242</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cocker</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Joss</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Compassion Fatigue among Healthcare, Emergency and Community Service Workers: A Systematic Review.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2016</year>
            <month>Jun</month>
            <day>22</day>
            <volume>13</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">27338436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r243">
          <label>243</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mystakidou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parpa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tsilika</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Athanasouli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pathiaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Galanos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pagoropoulou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vlahos</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Preparatory grief, psychological distress and hopelessness in advanced cancer patients.</article-title>
            <source>Eur J Cancer Care (Engl)</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-51</page-range>
            <pub-id pub-id-type="pmid">18302651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r244">
          <label>244</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quek</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>QL</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Anantham</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Malignant pleural effusion survival prognostication in an Asian population.</article-title>
            <source>Respirology</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>1283</fpage>
            <page-range>1283-1291</page-range>
            <pub-id pub-id-type="pmid">32390227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r245">
          <label>245</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clive</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Kahan</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Zahan-Evans</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bintcliffe</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Boshuizen</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Fysh</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Tobin</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Medford</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>van den Heuvel</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.</article-title>
            <source>Thorax</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>69</volume>
            <issue>12</issue>
            <fpage>1098</fpage>
            <page-range>1098-104</page-range>
            <pub-id pub-id-type="pmid">25100651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r246">
          <label>246</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Psallidas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kanellakis</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Gerry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;z&#x000e9;nas</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Samsonova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schiller</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Asciak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hallifax</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dobson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pavord</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Kessler</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Pass</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stathopoulos</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.</article-title>
            <source>Lancet Oncol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>7</issue>
            <fpage>930</fpage>
            <page-range>930-939</page-range>
            <pub-id pub-id-type="pmid">29908990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r247">
          <label>247</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiorelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mazzella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Angelo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Santini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Domenico</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Carlo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin.</article-title>
            <source>Interact Cardiovasc Thorac Surg</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>411</fpage>
            <page-range>411-8</page-range>
            <pub-id pub-id-type="pmid">26769731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r248">
          <label>248</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dipper</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maskell</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prognostication in malignant pleural effusion: One size does not fit all.</article-title>
            <source>Respirology</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>1229</fpage>
            <page-range>1229-1230</page-range>
            <pub-id pub-id-type="pmid">32734601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r249">
          <label>249</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwalk</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Ost</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Saltijeral</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>De La Garza</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Casal</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Eapen</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rinsurongkawong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rinsurongkawong</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elamin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Swisher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heymach</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Grosu</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations.</article-title>
            <source>Chest</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>159</volume>
            <issue>3</issue>
            <fpage>1256</fpage>
            <page-range>1256-1264</page-range>
            <pub-id pub-id-type="pmid">33217413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r250">
          <label>250</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khera</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Reporting and grading financial toxicity.</article-title>
            <source>J Clin Oncol</source>
            <year>2014</year>
            <month>Oct</month>
            <day>10</day>
            <volume>32</volume>
            <issue>29</issue>
            <fpage>3337</fpage>
            <page-range>3337-8</page-range>
            <pub-id pub-id-type="pmid">25199760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r251">
          <label>251</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kheir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Akulian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gesthalter</surname>
                <given-names>YB</given-names>
              </name>
            </person-group>
            <article-title>Indwelling Tunneled Pleural Catheters.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2019</year>
            <month>Dec</month>
            <day>01</day>
            <volume>200</volume>
            <issue>11</issue>
            <fpage>P20</fpage>
            <page-range>P20-P21</page-range>
            <pub-id pub-id-type="pmid">31774312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r252">
          <label>252</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>e0117032</fpage>
            <pub-id pub-id-type="pmid">25785456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-130747.r253">
          <label>253</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Terman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bohach</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Silvers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Colt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.</article-title>
            <source>Chest</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>126</volume>
            <issue>5</issue>
            <fpage>1529</fpage>
            <page-range>1529-39</page-range>
            <pub-id pub-id-type="pmid">15539723</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
